The 5-Minute Urology Consult (The 5-Minute Consult Series)

Unknown......Page 2
PREFACE......Page 5
EVIDENCE-BASED MEDICINE......Page 8
EDITOR-IN-CHIEF......Page 10
ASSOCIATE EDITORS......Page 11
SECTION EDITORS......Page 13
CONSULTING EDITORS......Page 14
SPECIALTY EDITORS......Page 17
INTERNATIONAL EDITORIAL BOARD......Page 23
CONTRIBUTORS......Page 28
SECTION I......Page 72
ABDOMINAL MASS, ADULT, UROLOGIC CONSIDERATIONS......Page 73
Taro Iguchi, MD, PhD......Page 74
ABDOMINAL MASS, NEWBORN/CHILD, UROLOGIC CONSIDERATIONS......Page 79
ACUTE TUBULAR NECROSIS (ATN)......Page 87
ADDISON DISEASE......Page 93
ADENOMATOID TUMORS, PARATESTICULAR......Page 101
1. Rubenstein RA, Dogra VS, Seftel AD, et al. Benign intrascrotal lesions. J Urol 2004;171:1765–1772.......Page 105
2. William SB, Han M, Jones R, et al. Adenomatoid tumor of the testes. Urology 2004;63:779.e3–779.e5.......Page 106
3. Dogra VS, Gottlieb RH, Oka M, et al. Sonography of the scrotum. Radiology 2003;27:18–36.......Page 107
4. Amin MB. Selected other problematic testicular and paratesticular lesions: Rete testis neoplasms and pseudotumors, mesothelial lesions and secondary tumors. Mod Path 2005;18:S131–S145.......Page 108
5. Tammela TL, Karttunen TJ, Mäkäräinen HP, et al. Intrascrotal adenomatoid tumors. J Urol 1991;146(1):61–65.......Page 109
ADRENAL ADENOMA......Page 110
ADRENAL ANGIOMYELOLIPOMA (AML)......Page 116
1. Meyer A, Behrend M. Presentation and therapy of myelolipoma. Int J Urol 2005;12:239–243.......Page 119
2. Kenney PJ, Wagner BJ, Rao P, et al. Myelolipoma: CT and pathologic features. Radiology 1998;208(1):87–95.......Page 120
3. Elsayes KM, et al. Adrenal masses: MRI imaging features with pathologic correlation. Radiographics 2004;24(Suppl 1):S73–S86.......Page 121
4. Han M, Burnett AL, Fishman EK, et al. The natural history and treatment of adrenal myelolipoma. J Urol 1997;157(4):1213–1216.......Page 122
ADRENAL CORTICAL CARCINOMA......Page 123
ADRENAL INSUFFICIENCY, ACUTE......Page 129
ADRENAL MASS......Page 136
1. Barzon L, Sonino N, Fallo F, et al. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 2003;149:273–285.......Page 143
2. Young WF. The incidentally discovered adrenal mass. N Engl J Med 2007;356:601–610.......Page 144
3. Ng L, Libertino JM. Adrenocortical carcinoma: Diagnosis, evaluation, and treatment. J Urol 2003;169:5–11.......Page 145
4. Guazzoni G, Cetsari F, Bellinzoni P, et al. Laparoscopic treatment of adrenal disease: 10 years on. Br J Urol 2004;93:221–227.......Page 146
AMYLOIDOSIS, GENITOURINARY......Page 147
ANDROPAUSE (LATE-ONSET HYPOGONADISM)......Page 152
ANORECTAL MALFORMATIONS: IMPERFORATE ANUS, CLOACA, AND UROGENITAL SINUS ANOMALIES......Page 158
1. Lau ST,Caty MG. Hindgut abnormalities. Surg Clin N Am 2006;86:301–316.......Page 164
2. Rink R, Kaefer M. Surgical management of intersexuality, cloacal malformation, and other abnormalities of the genitalia in girls. In: Wein AJ, et al. Campbell-Walsh Urology, 9th ed. Philadelphia: Saunders Elsevier, 2007.......Page 165
3. Keljo DJ, Gariepy CE. Anatomy, histology, embryology, and developmental anomalies of the small and large intestine. In: Feldman M, et al. Sleisenger and Fordtran’s GI and Liver Disease, 7th ed. Philadelphia: WB Saunders, 2002.......Page 166
4. Rich MA, Brock WA, Peña A. Spectrum of genitourinary malformations in patients with imperforate anus. Pediatr Surg Int 1988;3:110–113.......Page 167
5. Sheldon CA, Gilbert A, Lewis AG. Surgical implications of genitourinary tract anomalies in patients with imperforate anus. J Urol 1994;152:196–199.......Page 168
6. Boemers TM, Beek FJ, van Gool JD. Urologic problems in anorectal malformations. Part 1: Urodynamic findings and significance of sacral anomalies. J Pediatr Surg 1996;31:407–410.......Page 169
7. Teixeira OH. Cardiovascular anomalies with imperforate anus. Arch Dis Child 1983;58:747–749.......Page 170
8. Peña A. Anorectal malformations. Semin Pediatr Surg 1995;4:35–47.......Page 171
ANURIA AND OLIGURIA......Page 172
Table 1 Urinary Indices......Page 176
*Helpful when diuretics have been used......Page 177
1. Cantarovich F, Rangoonwala B, Lorenz H, et al. High-Dose Furosemide in Acute Renal Failure Study Group. High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kidney Dis 2004;44(3):402–409.......Page 180
AUTONOMIC DYSREFLEXIA......Page 181
1. Vaidyanathan S, Soni BM, Sett P, et al. Pathophysiology of autonomic dysreflexia: Long-term treatment with terazosin in adult and pediatric spinal cord injury patients manifesting recurrent dysreflexic episodes. Spinal Cord 1998;36:761–770.......Page 184
2. Chancellor M, Gajewski J, Ackman CFD, et al. Long-term follow-up of the North American Multicenter UroLume Trial for the treatment of external detrusor-sphincter dyssynergia. J Urol 1999;161:1545–1550.......Page 185
3. Hohenfellner M, Pannek J, Botel U, et al. Sacral bladder denervation for treatment of detrusor hyperreflexia and autonomic dysreflexia. Urology 2001;58:28–32.......Page 186
BACTERIURIA AND PYURIA......Page 187
1. Screening for asymptomatic bacteriuria in adults: US Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2008;149:43–47.......Page 193
BALANITIS AND BALANOPOSTHITIS......Page 195
BCG SEPSIS/BCGOSIS......Page 201
BLADDER AREFLEXIA (DETRUSOR AREFLEXIA)......Page 205
1. Dasgupta R, Wiseman OJ, Kitchen N, et al. Long-term results of sacral neuromodulation for women with urinary retention. BJU Int 2004;94:335–337.......Page 209
2. Jonas U, Fowler CJ, Chancellor MB, et al. Efficacy of sacral nerve stimulation for urinary retention: Results 18 months after implantation. J Urol 2001;165:15–19.......Page 210
3. van Kerrebroeck PE, van der Aa HE, Bosch JL, et al. Sacral rhizotomies and electrical bladder stimulation in spinal cord injury. Part I. Clinical and urodynamic analysis. Dutch Study Group on Sacral Anterior Root Stimulation. Eur Urol 1997;31:263–271.......Page 211
BLADDER CALCULI (VESICAL CALCULI)......Page 212
BLADDER CANCER, ADENOCARCINOMA......Page 219
1. Dahm P, Gschwend JE. Malignant non-urothelial neoplasms of the urinary bladder: A review. Eur Urol 2003;44:672–681.......Page 223
2. Siefker-Radtke AO, Gee J, Shen Y, et al. Multimodality management of urachal carcinoma: The MD Anderson Cancer Center experience. J Urol 2003;169:1295–1298.......Page 224
3. Siefker-Radtke A. Systemic chemotherapy options for metastatic bladder cancer. Expert Rev Anticancer Ther 2006;6:877–885.......Page 225
4. Herr HW, Bochner BH, Sharp D, et al. Urachal carcinoma: Contemporary surgical outcomes. J Urol 2007;178:74–78.......Page 226
5. El-Mekresh MM, el-Baz MA, Abol-Enein H, et al. Primary adenocarcinoma of the urinary bladder: A report of 185 cases. Br J Urol 1998;82(2):206–212.......Page 227
BLADDER CANCER, GENERAL......Page 228
1. Lamm DL, Blumenstein BA, Crissman JD, et al. Maintenance bacillus Calmette-Guérin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group Study. J Urol 2000;163:1124–1129.......Page 235
2. Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003:349:859–866.......Page 236
3. Shipley WU, Zietman AL, Kaufman DS, et al. Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates—The Massachusetts General Hospital and Radiation Therapy Oncology Group experiences. Semin Radiat Oncol 2005;15:36–41.......Page 237
BLADDER CANCER, SQUAMOUS CELL CARCINOMA......Page 239
BLADDER CANCER, UROTHELIAL SUPERFICIAL (CIS, TA, T1)......Page 245
1. O’Donnell MA. Practical applications of intravesical chemotherapy and immunotherapy in high-risk patients with superficial bladder cancer. Urol Clin North Am 2005;32:121–131.......Page 251
2. Friedrich MG, Pichlmeier U, Schwaibold H, et al. Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non–muscle-invasive bladder carcinoma. Eur Urol 2007;52:1123–1129.......Page 252
3. Lamm DL, Blumenstein BA, Crissman JD, et al. Maintenance Bacillus Calmette-Guérin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group Study. J Urol 2000;163:1124–1129.......Page 253
4. Joudi FN, Smith BJ, O’Donnell MA, et al. Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer. Urol Oncol 2006;24:344–348.......Page 254
5. Lamm DL, Riggs DR, Shriver JS, et al. Megadose vitamins in bladder cancer: A double-blind clinical trial. J Urol 1994;151:21–26.......Page 255
BLADDER CANCER, UROTHELIAL, INVASIVE (T2/3/4)......Page 256
BLADDER CANCER, UROTHELIAL, METASTATIC (N+, M+)......Page 262
BLADDER INJURY, INTRAOPERATIVE......Page 267
BLADDER OUTLET OBSTRUCTION (BOO)......Page 271
BLADDER TRAUMA......Page 277
1. Udekwu PO, Gurkin B, Oller DW, et al. The use of computed tomography in blunt abdominal injuries. Am Surg 1996;62:56–59.......Page 282
2. Parry NG, Pozycki GS, Feliciano DV, et al. Traumatic rupture of the urinary bladder: Is the suprapubic tube necessary? J Trauma 2003;54:431–436.......Page 283
3. Aihara R, Blansfield JS, Millham FH, et al. Fracture locations influence the likelihood of rectal and lower urinary tract injuries in patients sustaining pelvic fractures. J Trauma 2002;52(2):205–209.......Page 284
4. Gomez RG, Ceballos L, Coburn M, et al. Consensus statement on bladder injuries. BJU Int 2004;94(1):27–32.......Page 285
5. Quagliano PV, Delair SM, Malhotra AK. Diagnosis of blunt bladder injury: A prospective comparative study of computed tomography cystography and conventional retrograde cystography. Trauma 2006;61(2):410–421.......Page 286
6. Alli MO, Singh B, Moodley J, et al. Prospective evaluation of combined suprapubic and urethral catheterization to urethral drainage alone for intraperitoneal bladder injuries. J Trauma Injury Infection Crit Care 2003;55(6):1152–1154.......Page 287
BLADDER TUMORS, BENIGN AND MALIGNANT, GENERAL......Page 288
1. American Cancer Society: Cancer Facts and Figures 2009, Atlanta, GA.......Page 294
2. Hall MC, Chang SS, Dalbagni G, et al. AUA guideline for the management of non–muscle invasive bladder cancer (Ta, T1, CIS): 2007 Update.......Page 295
3. Messing EM. Urothelial tumors of the bladder. In: Wein AJ, Kavoussi LR, Novick AC, et al., eds. Campbell-Walsh Urology, 9th ed., Philadelphia: Saunders, 2007:2407–2446.......Page 296
BOWEN DISEASE AND ERYTHROPLASIA OF QUEYRAT......Page 297
BURNS, EXTERNAL GENITALIA AND PERINEUM......Page 303
CALYCEAL DIVERTICULUM......Page 308
1. Streem SB, Yost A. Treatment of caliceal diverticular calculi with extracorporeal shock wave lithotripsy: Patient selection and extended followup. J Urol 1992;148:1043–1046.......Page 312
2. Chong TW, Bui MH, Fuchs GJ. Calyceal diverticula. Ureteroscopic management. Urol Clin North Am 2000;27:647–654.......Page 313
3. Kim SC, Kuo RL, Tinmouth WW, et al. Percutaneous nephrolithotomy for caliceal diverticular calculi: A novel single stage approach. J Urol 2005;173:1194–1198.......Page 314
4. Miller SD, Ng CS, Streem SB, et al. Laparoscopic management of caliceal diverticular calculi. J Urol 2002;167:1248–1252.......Page 315
5. Auge BK, Maloney ME, Mathias BJ, et al. Metabolic abnormalities associated with calyceal diverticular stones. BJU Int 2006;97:1053–1056.......Page 316
CATHETERIZABLE STOMA PROBLEMS......Page 317
1. Thomas JC, Dietrich MS, DeMarco RT, et al. Continent catheterizable channels and the timing of their complications. J Urol 2006;176:1816–1820.......Page 322
2. Farnham SB, Cookson MS. Surgical complications of urinary diversion. World J Urol 2004;22:157–167.......Page 323
3. Hellenthal NJ, Eandi JA, Delair SM, et al. Umbilical stomal stenosis: A simple surgical revision technique. Urology 2007;69:771–772.......Page 324
CHORDEE......Page 325
CHYLURIA......Page 329
CONDYLOMA ACUMINATA (VENEREAL WARTS)......Page 334
CONTRAST ALLERGY AND REACTIONS......Page 340
1. Cochran ST, Bomyea K. Trends in adverse events from iodinated contrast media. Acad Radiol 2002;9(Suppl 1):S65–S68.......Page 344
2. Hagan JB. Anaphylactoid and adverse reactions to radiocontrast agents. Immunol Allergy Clin N Am 2004;24:507–519.......Page 345
3. Liccardi G, Lobefalo G, Di Florio E, et al. Strategies for the prevention of asthmatic, anaphylactic and anaphylactoid reactions during the administration of anesthetics and/or contrast media. J Investig Allergy Clin Immunol 2008;18(1):1–11.......Page 346
CUSHING DISEASE AND SYNDROME......Page 347
CYSTITIS, GENERAL......Page 352
CYSTITIS, HEMORRHAGIC (INFECTIOUS, NONINFECTIOUS, RADIATION)......Page 359
1. Vose JM, Reed EC, Pippert GC, et al. Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: A randomized trial. J Clin Oncol 1993;11:1306–1310.......Page 365
2. Veerasarn V, Khorprasert C, Lorvidhaya V, et al. Reduced recurrence of late hemorrhagic radiation cystitis by WF10 therapy in cervical cancer patients: A multicenter, randomized, 2-arm, open-label trial. Radiother Oncol 2004;73:179–185.......Page 366
3. Corman JM, McClure D, Pritchett R, et al. Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen. J Urol 2003;169:2200–2202.......Page 367
CYSTOCELE......Page 368
DEEP VENOUS THROMBOSIS AND PULMONARY EMBOLISM, UROLOGIC CONSIDERATIONS......Page 373
1. Stein PD, Hull RD, Patel KC, et al. D-Dimer for the exclusion of acute venous thrombosis and pulmonary embolism: A systematic review. Ann Intern Med 2004;140:589–602.......Page 378
2. Hogg K, Brown G, Dunning J, et al. Diagnosis of pulmonary embolism with CT pulmonary angiography: A systematic review. Emerg Med J 2006;23:172–178.......Page 379
3. Roy PM, Colombet I, Durieux P, et al. Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism. BMJ 2005;331:259.......Page 380
DETRUSOR OVERACTIVITY......Page 381
DETRUSOR-SPHINCTER DYSSYNERGIA (DSD)......Page 387
1. Schurch B, Hauri D, Rodic B, et al. Botulinum-A toxin as treatment of detrusor sphincter dyssynergia: A prospective study in 24 spinal cord injury patients. J Urol 1996;155:1023–1029.......Page 394
2. Chancellor M, Gajewski J, Ackman CFD, et al. Long-term follow-up of the North American Multicenter UroLume Trial for the treatment of external detrusor-sphincter dyssynergia. J Urol 1999;161:1545–1550.......Page 395
DIABETES MELLITUS, UROLOGIC CONSIDERATIONS......Page 397
1. Walsh P. Campbell-Walsh Urology. Philadelphia: Saunders, 2007.......Page 402
2. Costabile R. Optimizing treatment for diabetes mellitus induced erectile dysfunction. J Urol 2003;170:S35–S38.......Page 403
3. Goldstraw MA, et al. Diabetes and the urologist: A growing problem. Br J Urol 2006;99:513–517.......Page 404
DISORDERS OF SEXUAL DEVELOPMENT (DSD)......Page 406
DYSPAREUNIA......Page 414
DYSURIA......Page 420
EDEMA, EXTERNAL GENITALIA (PENO–SCROTAL EDEMA)......Page 427
EJACULATION, PREMATURE......Page 432
EJACULATORY DISTURBANCES (DELAYED, ABSENT, REDUCED)......Page 436
ENURESIS, ADULT......Page 441
2. Wadie BS. Primary nocturnal enuresis persistent to adulthood, functional evaluation. Neurourol Urodynam 2004;23:54–57.......Page 446
3. Yeung CK, Sihoe JD, Sit FK, et al. Urodynamic findings in adults with primary nocturnal enuresis. J Urol 2004;171:2595–2598.......Page 447
4. Vandersteen DR, Husmann DA. Treatment of primary nocturnal enuresis persisting into adulthood. J Urol 1999;161:90–92.......Page 448
5. Yucel S, Kutlu O, Kukul E, et al. Impact of urodynamics in treatment of primary nocturnal enuresis persisting into adulthood. Urology 2004;64:1020–1025; discussion 1025.......Page 449
6. Kayigil O, Aytac B, Cakar KS, et al. Clam ileocystoplasty in adult nocturnal enuresis. Intern Urol Nephrol 2001;32:647–649.......Page 450
ENURESIS, PEDIATRIC......Page 451
EPIDIDYMIS, MASS (EPIDIDYMAL TUMORS AND CYSTS)......Page 458
EPIDIDYMITIS......Page 462
1. Nickel JC, Teichman JMH, Gregoire M, et al. Prevalence, diagnosis, characterization, and treatment of prostatitis, interstitial cystitis, and epididymitis in outpatient urological practice: The Canadian PIE Study. Urology 2005;66(5):935–940.......Page 468
2. Höppner W, Strohymer T, Hartmann M, et al. Surgical treatment of acute epididymitis and its underlying diseases. Eur Urol 1992;22(3):218–221.......Page 469
3. Calleary JG, Masood J, Hill JT. Chronic epididymitis: Is epididymectomy a valid surgical treatment? Intern J Androl Epub ahead of print, 2008.......Page 470
EPISPADIAS......Page 471
1. Gearhart JP, Mathews R. Exstrophy-epispadias complex. In: Wein AJ, et al. Campbell-Walsh Urology, 9th ed. Philadelphia: Saunders Elsevier, 2007.......Page 476
2. Kramer SA, Kelalis PP. Assessment of urinary continence in epispadias: Review of 94 patients. J Urol 1982;128:290–293.......Page 477
4. Ben-Chaim J, et al. Complete male epispadias: Genital reconstruction and achieving continence. J Urol 1995;153:1665–1667.......Page 478
5. Gearhart JP, Peppas DS, Jeffs RD. Complete genitourinary reconstruction in female epispadias. J Urol 1993;149:1110–1113.......Page 479
6. Mesrobian HJ, Kelalis PP, Kramer SA. Long-term followup of cosmetic appearance and genital function in boys with exstrophy: Review of 53 patients. J Urol 1986;136:256–258.......Page 480
7. Kajbafzadeh AM, Duffy PG, Ransley PG. The evolution of penile reconstruction in epispadias repair: A report of 180 cases. J Urol 1995;154:858–861.......Page 481
ERECTILE DYSFUNCTION FOLLOWING PELVIC SURGERY OR RADIATION......Page 482
5. Miles CL, Candy B, Jones L, et al. Interventions for sexual dysfunction following treatments for cancer. Cochrane Database Syst Rev 2007;(4):CD005540.......Page 487
ERECTILE DYSFUNCTION/IMPOTENCE (ED)......Page 488
1. Lue TF. Physiology of penile erection and pathophysiology of erectile dysfunction. In: Wein AJ, et al. Campbell-Walsh Urology, 9th ed. Philadelphia: Saunders-Elsevier, 2007.......Page 495
2. Mulhall JP. Erectile dysfunction. In: Gomella LG, ed. 5-Minute Urology Consult, 1st ed. Philadelphia: Lippincott Williams & Wilkins, 2000.......Page 496
3. Carson CC, Lue TF. Phosphodiesterase type 5 inhibitors for erectile dysfunction. BJU 2005;96:257–280.......Page 497
4. Lue TF, Broderick GA. Evaluation and nonsurgical management of erectile dysfunction and premature ejaculation. In: Wein AJ, et al. Campbell-Walsh Urology, 9th ed. Philadelphia: Saunders-Elsevier, 2007.......Page 498
5. Montague DK, Jarow JP, Broderick GA, et al. Chapter 1: The management of erectile dysfunction: An AUA update. J Urol 2005;174(1):230–239.......Page 499
EXSTROPHY, BLADDER (CLASSIC EXTROPHY)......Page 500
EXSTROPHY, CLOACAL......Page 504
FILLING DEFECT, UPPER URINARY TRACT......Page 510
1. Raman JD, Scherr DS. Management of patients with upper urinary tract transitional cell carcinoma. Nat Clin Pract Urol 2007;4(8):432–443.......Page 515
2. Bagley DH. Treatment of upper urinary tract neoplasms. In: Smith AD, et al., eds. Smith’s Textbook of Endourology. St Louis: Quality Medical Publishing; 1996.......Page 516
3. Clayman RV, et al. Endourology of the upper urinary tract: Noncalculous applications. In: Gillen-water JY, Grayhack JT, Howards SS, et al., eds. Adult and Pediatric Urology. St Louis: Mosby-Year Book; 1996.......Page 517
FLANK PAIN......Page 518
FOLEY CATHETER PROBLEMS (INSERTION AND REMOVAL)......Page 525
FOURNIER GANGRENE......Page 532
1. Sorensen MD, Broghammer JA, Rivara FP, et al. Fournier’s gangrene: Contemporary population-based incidence and outcomes analysis: A HCUP database study. J Urol 2008;179(4):13.......Page 537
2. Vick R, Carson CC 3rd. Fournier’s disease. Urol Clin North Am 1999;26(4):841–849.......Page 538
3. Joseph E, Hamori CA, Bergman S, et al. A prospective randomized trial of vacuum-assisted closure vs. standard therapy of chronic non-healing wounds. Wounds 2000;12(3):60–67.......Page 539
4. Mindrup SR, Kealey GP, Fallon B. Hyperbaric oxygen for the treatment of Fournier’s gangrene. J Urol 2005;173:1975–1977.......Page 540
5. Gilbert DN, Moellering RC, Eliopoulos GM, et al. The Sanford Guide to Antimicrobial Therapy, 38th ed. Sperryville: Antimicrobial Therapy Inc., 2008.......Page 541
FUNGAL INFECTIONS, GENITOURINARY......Page 542
GLOMERULONEPHRITIS, ACUTE......Page 549
GLOMERULONEPHRITIS, CHRONIC......Page 554
1. Hricik DE, Chung-Park M, Sedor JR, et al. Glomerulonephritis. N Engl J Med 1998;339(13):888–899.......Page 559
2. Couser WG. Glomerulonephritis. Lancet 1999;353:1509–1515.......Page 560
3. Mookerjee BK, et al. Glomerulonephritis for the generalist. J Med 2001;32(3,4):115–134.......Page 561
GONORRHEA......Page 562
GROIN HERNIA, ADULT AND PEDIATRIC......Page 567
1. Fitzgibbons RJ, Giobbe-Hurder A, Gibbs J, et al. Watchful waiting vs repair of inguinal hernia in minimally symptomatic men: A randomized clinical trial. JAMA 2006;295:285–292.......Page 572
2. van Veen RN, Wijsmuller AR, Vrijland WW, et al. Randomized clinical trial of mesh vs. non-mesh primary inguinal hernia repair: Long-term chronic pain at 10 years. Surgery 2007;142(5):695–698.......Page 573
3. Berndsen FH, Petersson U, Arvidsson D, et al. Discomfort 5 years after laparoscopic and Shouldice inguinal hernia repair: A randomised trial with 867 patients. A report from the SMIL study group. Hernia 2007;11(4):307–313.......Page 574
GROIN/INGUINAL MASS......Page 575
GYNECOMASTIA......Page 582
HEMATOSPERMIA......Page 589
HEMATURIA, GROSS AND MICROSCOPIC, ADULT......Page 596
1. Sutton JM. Evaluation of hematuria in adults. JAMA 1990;263:2475–2480.......Page 602
2. Khadra MH, Pickard RS, Charlton M, et al. A prospective analysis of 1930 patients with hematuria to evaluate current diagnostic practice. J Urol 2000;163:524–527.......Page 603
3. Grossfeld GD, Litwin MS, Wolf JS, et al. Evaluation of asymptomatic microscopic hematuria in adults: The American Urological Association best practice policy–part I: Definition, detection, prevalence, and etiology. Urology 2001;57:599–603.......Page 604
4. Grossfeld GD, Litwin MS, Wolf JS Jr, et al. Evaluation of asymptomatic microscopic hematuria in adults: The American Urological Association best practice policy–part II: Patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology 2001;57:604–610.......Page 605
HEMATURIA, GROSS AND MICROSCOPIC, PEDIATRIC......Page 607
HEMORRHAGE POST-TURP......Page 615
1. Normand G, et al. Macroscopic haematuria after transurethral resection of the prostate. Prog Urol 2006;16(4):461–463.......Page 619
2. Littlejohn JO, et al. Transurethral resection of the prostate: The new old standard. Curr Opin Urol 2002;12:19–23.......Page 620
3. Wasson J, et al. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia: The veterans affair cooperative study group. N Engl J Med 1995;332:75–79.......Page 621
4. Roehrborn CG, et al. The agency for health care policy and research. Clinical guidelines for the diagnosis and treatment of benign prostatic hyperplasia. Urol Clin North Am 1995;22(2):445–453.......Page 622
5. Ehrlich Y, et al. Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: A prospective randomized trial. J Urol 2007;178(2):524–528.......Page 623
6. Hahn RG, et al. Blood loss and postoperative complications associated with transurethral resection of the prostate after pretreatment with dutasteride. Br J Urol 2007;99:587–594.......Page 624
7. Rastinehad AR, et al. Selective arterial prostatic embolization (SAPE) for refractory hematuria of prostatic origin. Urology 2008;71:181–184.......Page 625
HERPES SIMPLEX, GENITAL......Page 627
HESITANCY AND INTERMITTENCY......Page 632
HIV/AIDS, UROLOGIC CONSIDERATIONS......Page 640
HOT FLUSHES (VASOMOTOR INSTABILITY)......Page 646
1. Baum NH, Torti DC. Managing hot flashes in men being treated for prostate cancer. Geriatrics 2007;62:18–21. [C]......Page 651
2. Gerber GS, Zagaja GP, Ray PS, et al. Transdermal estrogen in the treatment of hot flushes in men with prostate cancer. Urology 2000;55:97–101.......Page 652
3. Langenstroer P, Kramer B, Cutting B, et al. Parenteral medroxyprogesterone for the management of luteinizing hormone releasing hormone induced hot flashes in men with advanced prostate cancer. J Urol 2005;174:642–645.......Page 653
4. Loprinzi CL, Barton DL, Carpenter LA, et al. Pilot evaluation of paroxetine for treating hot flashes in men. Mayo Clin Proc 2004;79:1247–1251.......Page 654
HYDROCELE, ADULT AND PEDIATRIC......Page 655
HYDROCOLPOS AND HYDROMETROCOLPOS......Page 660
HYDRONEPHROSIS/HYDROURETERONEPHROSIS (DILATED URETER/RENAL PELVIS), ADULT......Page 664
1. Pais VR, Strandhoy JW, Assimos D. Pathophysiology of urinary tract obstruction. In: Wein A, et al. Campbell-Walsh Urology, 9th ed. Philadelphia: Saunders Elsevier, 2007.......Page 670
2. Shapiro SR, Wahl EF, et al. Hydronephrosis Index: A new method to track patients with hydronephrosis quantitatively. Urology 2008, Epub ahead of print.......Page 671
3. Koelliker SL, Cronan JJ. Acute urinary tract obstruction: Imaging update. Urol Clin North Am 1997;24:571.......Page 672
4. Grattan-Smith JD, Little SB, et al. MR urography evaluation of obstructive uropathy. Pediatr Radiol. 2008;38,1:S49–S69.......Page 673
5. Docimo SG, Silver RI. Renal ultrasonography in newborns with prenatally detected hydronephrosis. J Urol 1997;157:1387.......Page 674
HYDRONEPHROSIS/HYDROURETERONEPHROSIS (DILATED URETER/RENAL PELVIS), PEDIATRIC......Page 675
1. Thomas DF. Fetal uropathy. Br J Urol 1990;66:225–231.......Page 681
2. Bornstein E, Barnhard Y, Donnenfeld AE. The risk of a major trisomy in fetuses with pyelectasis: The impact of an abnormal maternal serum screen or additional sonographic markers. Am J Obstet Gynecol 2007;196:e24–e26.......Page 682
3. Palmer JS. Genitourinary manifestations in boys and girls associated with genetic diseases. J Men’s Health & Gender 2006;3:71–79.......Page 683
4. Churchill BM, Sheldon CA, McLorie GA. The ectopic ureterocele: A proposed practical classification based on renal unit jeopardy. J Pediatr Surg 1992;27:497–500.......Page 684
5. McGuire EJ. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 1981;126:205–209.......Page 685
HYDRONEPHROSIS/HYDROURETERONEPHROSIS (DILATED URETER/RENAL PELVIS), PRENATAL......Page 686
HYPERALDOSTERONISM, PRIMARY (ALDOSTERONISM, CONN SYNDROME)......Page 691
HYPERPROLACTINEMIA, UROLOGIC CONSIDERATIONS......Page 698
HYPOSPADIAS......Page 705
1. Kalfa N, Philibert P, Sultan C. Is hypospadias a genetic, endocrine or environmental disease, or still an unexplained malformation? Int J Androl, 2008.......Page 711
2. Baskin LS, Ebbers MB. Hypospadias: Anatomy, etiology, and technique. J Pediatr Surg 2006;41:463–472.......Page 712
3. Markiewicz MR, Lukose MA, Margarone JE, et al. The oral mucosa graft: A systematic review. J Urol 2007;178:387–394.......Page 713
INCONTINENCE, URINARY, ADULT FEMALE......Page 714
INCONTINENCE, URINARY, ADULT MALE......Page 721
1. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the US. World J Urol 2003;20:327–336.......Page 726
2. Anger JT, Saigal CS, Stothers L, Thom DH, Rodriguez LV, Litwin MS. Urologic Diseases of America Project. The prevalence of urinary incontinence among community dwelling men: Results from the National Health and Nutrition Exam survey. J Urol 2006;176(5):2103–2108.......Page 727
3. Comiter CV. The male sling for stress urinary incontinence: A prospective study. J Urol 2002;167:597–601.......Page 728
4. Elliott DS, Barrett DM. Mayo Clinic long-term analysis of the functional durability of the AMS 800 artificial urinary sphincter: A review of 323 cases. J Urol 1998;159:1206–1208.......Page 729
INCONTINENCE, URINARY, FOLLOWING RADICAL PROSTATECTOMY......Page 730
INCONTINENCE, URINARY, PEDIATRIC......Page 735
INFERTILITY, UROLOGIC CONSIDERATIONS......Page 743
1. Schoor RA, Elhanbly S, Niederberger CS, et al. The role of testicular biopsy in the modern management of male infertility. J Urol 2002;167:197–270.......Page 749
2. Hussein A, Ozgok Y, Ross L, et al. Clomiphene administration for cases of nonobstructive azoospermia: A multicenter study. J Androl 2005;26:787–791.......Page 750
3. Agarwal A, Deepinder F, Cocuzza M, et al. Efficacy of varicocelectomy in improving semen parameters: New meta-analytical approach. Urology 2007;70:532–538.......Page 751
4. Belker AM, Thomas AJ, Fuchs EF, et al. Results of 1469 microsurgical vasectomy reversals by the vasovasotomy study group. J Urol 1991;145:505–511.......Page 752
5. Guven S, Gunalp GS, Tekin Y. Factors influencing pregnancy rates in intrauterine insemination cycles. J Reprod Med 2008;53:257–265.......Page 753
INTERSTITIAL CYSTITIS......Page 755
LATEX ALLERGY, UROLOGIC CONSIDERATIONS......Page 762
1. Agarwal S, Gawkrodger D. Latex allergy: A health care problem of epidemic proportions. Eur J Dermatol 2002;112(4):311–315.......Page 767
2. Obojski A, Chodorski J, Barg W, et al. Latex allergy and sensitization in children with spina bifida. Pediatr Neurosurg 2002;37(5):262–266.......Page 768
3. Nieto A, Mazon A, Pamies R, et al. Efficacy of latex avoidance for primary prevention of latex sensitization in children with spina bifida. J Pediatr 2002;140(3):370–372.......Page 769
4. Michael T, Niggemann B, Moers A, et al. Risk factors for latex allergy in patients with spina bifida. Clin Exp Allergy 1996;26(8):934–939.......Page 770
5. Cremer R, Lorbacher M, Hering F, et al. Natural rubber latex sensitization and allergy in patients with spina bifida, urogenital disorders and oesophageal atresia compared with a normal paediatric population. Eur J Pediatr Surg 2007;17(3):194–198.......Page 771
LIBIDO, DIMINISHED......Page 772
LYMPHADENOPATHY, INGUINAL......Page 777
1. Culkin DJ, Beer TM. Advanced penile carcinoma. J Urol 2003;170:359–365.......Page 783
Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2006. Department of Health and Human Services, November 2007.......Page 784
3. Sexually Transmitted Diseases Guidelines 2006. MMWR 2006;55(RR–11):1–100.......Page 785
LYMPHADENOPATHY, PELVIC AND RETROPERITONEAL......Page 786
1. Neville A, Herts BR. CT characteristics of primary retroperitoneal neoplasms. Crit Rev Comput Tomogr 2004;45(4):247–270.......Page 790
2. Bouchelouche K, Oehr P. Recent developments in urologic oncology: Positron emission tomography molecular imaging. Curr Opin Oncol 2008;20(3): 321–326.......Page 791
3. Carucci LR, Halvorsen RA. Abdominal and pelvic CT in the HIV-positive population. Abdom Imaging 2004;29(6):631–642.......Page 792
LYMPHOCELE, PELVIC......Page 793
MEDULLARY CYSTIC KIDNEY DISEASE (MCKD)......Page 798
1. Scolari F, Viola BF, Prati E, et al. Medullary cystic kidney disease: Past and present. Contrib Nephrol 2001;136:68–78.......Page 801
2. Weichhart T, Zlabinger GJ, Säemann MD. The multiple functions of Tamm-Horsfall protein in human health and disease: A mystery clears up. Wien Klin Wochenschr 2005;117(9–10):316–322.......Page 802
3. Hildebrandt F, Omram H. New insights: Nephronophthisis-medullary cystic kidney disease. Pediatr Nephrol 2001;16:168–176.......Page 803
MEDULLARY SPONGE KIDNEY (MSK)......Page 804
1. Ginalski JM, Portmann L, Jaeger P. Does medullary sponge kidney cause nephrolithiasis? AJR 1990;155:299–302.......Page 807
2. Osther PJ, Hansen AB, Rohl HF. Renal acidification defects in medullary sponge kidney. BJU 1988;61:392–394.......Page 808
3. Yagisawa T, Kobayashi C, Hayashi T, et al. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney. Am J Kidney Dis 2001;37:1140–1143.......Page 809
4. Higashihara E, Nutahara K, Niijima T. Renal hypercalciuria and metabolic acidosis associated with medullary sponge kidney: Effect of alkali therapy. Urol Res 1988;6:95–100.......Page 810
5. Deliveliotis C, Sofras F, Karagiotis E, et al. Management of lithiasis in medullary sponge kidneys. Urologia Internationalis 1996;57:185–187.......Page 811
MEGAURETER, CONGENITAL......Page 812
1. King LR. Megaloureter: Definition, diagnosis and management. J Urol 1980;123:222–223.......Page 817
2. Hohenfeller K, et al. Angiotensin type 2 receptor is important in the normal development of the ureter. Pediatr Nephrol 1999;13:187–191.......Page 818
3. Lee BR, Silver RI, Partin AW, et al. A quantitative histologic analysis of collagen subtypes: The primary obstructed and refluxing megaureter of childhood. Urology 1998;51:820–823.......Page 819
4. Starr A. Ureteral plication. Invest Urol 1979;17:153–158.......Page 820
5. Kaliscinski ZH, Kansy J, Kotarbinska B, et al. Surgery of megaureters—modification of Hendren’s operation. J Pediatr Surg 1977;12:183–188.......Page 821
6. Hendren WH. Operative repair of megaureter in children. J Urol 1969;101:491–507.......Page 822
7. McLellan DL, Retik AB, Bauer SB, et al. Rate and predictors of spontaneous resolution of prenatally diagnosed primary nonrefluxing megaureter. J Urol 2002;168:2177–2180.......Page 823
8. Peters CA, Manell J, Lebowitz RL, et al. Congenital obstructed megaureters in early infancy: Diagnosis and treatment. J Urol 1989;142:641–645.......Page 824
9. Dawrant MJ, Mohanan N, Puri P. Endoscopic treatment for high grade vesicoureteral reflux in infants. J Urol 2006;176:1847–1850.......Page 825
MESOBLASTIC NEPHROMA, CONGENITAL (BOLANDE DISEASE)......Page 826
MICROPENIS (MICROPHALLUS)......Page 830
MULTICYSTIC DYSPLASTIC KIDNEY......Page 838
1. Ismaili K, Avni FE, Alexander M, et al. Routine voiding cystourethrography is of no value in neonates with unilateral multicystic dysplastic kidney. J Pediatr 2005;146:759–763.......Page 841
2. Cambio AJ, Evans CP, Kurzrock EA. Non-surgical management of multicystic dysplastic kidney. BJU Int 2008;101:804–808.......Page 842
3. Narchi H. Risk of HTN with multicystic kidney disease: A systematic review. Arch Dis Child 2005;90:921–924.......Page 843
MULTIPLE SCLEROSIS, UROLOGIC CONSIDERATIONS......Page 844
MYASTHENIA GRAVIS, UROLOGIC CONSIDERATIONS......Page 851
MYELODYSPLASIA, UROLOGIC CONSIDERATIONS......Page 856
NEPHROCALCINOSIS......Page 863
NEPHROTIC SYNDROME......Page 870
1. Hodson EM, Willis NS, Craig JC. Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev 2007:CD001533.......Page 876
2. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: A meta-analysis. Kidney Int 2001;59:260–269.......Page 877
3. Nakao N, Yoshimura A, Morita H, et al. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): A randomised controlled trial. Lancet 2003;361:117–124.......Page 878
4. Hodson EM, Willis NS, Craig JC. Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database Syst Rev 2008:CD002290.......Page 879
NEUROBLASTOMA......Page 881
NEUROGENIC BLADDER, GENERAL......Page 889
1. Schurch B, Hauri D, Rodic B, et al. Botulinum-A toxin as treatment of detrusor sphincter dyssynergia: A prospective study in 24 spinal cord injury patients. J Urol 1996;155:1023–1029.......Page 896
2. Chancellor M, Gajewski J, Ackman CFD, et al. Long-term follow-up of the North American Multicenter UroLume Trial for the treatment of external detrusor-sphincter dyssynergia. J Urol 1999;161:1545–1550.......Page 897
3. Linsenmeyer TA, Culkin D. APS recommendations for urological evaluation of patients with spinal cord injury. J Spinal Cord Med 1999;22:139–142.......Page 898
NOCTURIA......Page 899
1. Pressman MR, et al. Nocturia. A rarely recognized symptom of sleep apnea and other occult sleep disorders. Arch Intern Med 1996;156:545.......Page 905
2. Fitzgerald MP, et al. The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: Results from the BACH survey. J Urol 2007;177:1385–1389.......Page 906
3. Johnson TM, et al. Effects of behavioral and drug therapy on nocturia in older incontinent women. J Am Geriatr Soc 2005;53:846.......Page 907
4. Johnson TM, et al. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. J Urol 2007;178:2045.......Page 908
5. Mattiasson A, et al. Efficacy of desmopressin in the treatment of nocturia: A double-blind placebo-controlled study in men. BJU Int 2002;89:855.......Page 909
6. Van Kerrebroeck PE, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: Outcomes of a prospective, worldwide clinical study. J Urol 2007;78:2029.......Page 910
ORCHITIS, GENERAL......Page 912
OVERACTIVE BLADDER (OAB)......Page 918
PAPILLARY NECROSIS, RENAL......Page 923
1. Griffin MD, et al. Renal papillary necrosis—A sixteen-year clinical experience. J Am Soc Nephrol 1995;6:248–256.......Page 928
2. Jung DC, et al. Renal papillary necrosis: Review and comparison of findings at multi-detector row CT and intravenous urography. RadioGraphics 2006;26:1827–1836.......Page 929
3. Brix AE. Renal papillary necrosis. Toxicol Pathol 2002;30(6):672–674.......Page 930
4. Dieleman JP, et al. Papillary necrosis associated with the HIV protease inhibitor indinavir. Infection 2001;29(4):232–233.......Page 931
PARATESTICULAR TUMORS, GENERAL......Page 932
PARKINSON DISEASE, UROLOGIC CONSIDERATIONS......Page 939
PELVIC PAIN, FEMALE......Page 944
PELVIC PAIN, MALE (NIH III B. NON-INFLAMMATORY CHRONIC PELVIC PAIN SYNDROME)......Page 951
PELVIC PROLAPSE (CYSTOCELE AND ENTEROCELE)......Page 958
PENILE PROSTHESIS PROBLEMS (INFECTION/EXTRUSION/MALFUNCTION)......Page 965
PENIS, CANCER, GENERAL......Page 972
PENIS, CURVATURE AND/OR PAIN......Page 978
PENIS, LESION, GENERAL......Page 984
PENIS, SQUAMOUS CELL CARCINOMA......Page 991
PENIS, TRAUMA (FRACTURE, STRANGULATION, AMPUTATION)......Page 998
PEYRONIE DISEASE......Page 1004
1. Hellstrom WJ, Bivalacqua TJ. Peyronie’s disease: Etiology, medical, and surgical therapy. J Androl 2000;21(3):347–354.......Page 1009
2. Jordan GH. Peyronie’s Disease. In: Wein AJ, et al. Campbell-Walsh Urology, 9th ed. Philadelphia: Saunders-Elsevier, 2007.......Page 1010
3. Sommer F, Schwarzer U, Wassmer G, et al. Epidemiology of Peyronie’s disease. Int J Impot Res 2002;14:379–383.......Page 1011
4. Steele BW, Carson CC. Peyronie disease. In: Gomella LG, ed. 5-Minute Urology Consult, 1st ed. Baltimore: Lippincott Williams & Wilkins, 2000.......Page 1012
5. Mulhall JP. Erectile dysfunction. In: Gomella LG, ed. 5-Minute Urology Consult, 1st ed. Baltimore: Lippincott Williams & Wilkins, 2000.......Page 1013
6. Jordan GH. The use of intralesional clostridial collagenase injection therapy for Peyronie’s disease: A prospective, single-center, non-placebo-controlled study. J Sex Med 2008;5(1):180–187.......Page 1014
7. Hellstrom WJ, Kendirci M, Matern R, et al. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon α-2b for minimally invasive treatment for Peyronie’s disease. J Urol 2006;176:394–398.......Page 1015
PHEOCHROMOCYTOMA......Page 1016
PHIMOSIS AND PARAPHIMOSIS......Page 1023
PNEUMATURIA (GAS IN URINE)......Page 1029
1. Najjar SF, Jamal MK, Savas JF, et al. The spectrum of colovesical fistula and diagnostic paradigm. Am J Surg 2004;188:617–621.......Page 1033
2. Gruner JS, Sehon JK, Johnson LW. Diagnosis and management of enterovesical fistulas in patients with Crohn’s disease. Am Surg 2002;68:914–719.......Page 1034
3. Medagrma UA, Aluvibare AP, Jayasiaghe MW, et al. A gas forming renal abscess in a person with diabetes mellitus and adult polycystic kidney disease. Diabetes Res Clin Pract 2006;75:372–373.......Page 1035
4. Jain D, et al. Emphysematous pyelonephritis: A rare cause of pneumaturia. Lancet 2001;357:1210.......Page 1036
5. Dulta P, Bhansali A, Singh SK, et al. Presentation and outcome of emphysematous renal tract disease in patients with diabetes mellitus. Urol Int 2007: 78:13–22.......Page 1037
POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL DOMINANT (ADPKD)......Page 1038
POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE (ARPKD)......Page 1045
POLYHYDRAMNIOS/OLIGOHYDRAMNIOS......Page 1052
POSTERIOR URETHRAL VALVES......Page 1058
POSTOBSTRUCTIVE DIURESIS (POD)......Page 1064
1. Li C, et al. Downregulation of AQP1, -2, and -3 after ureteral obstruction is associated with a long term urine concentrating defect. Am J Physiol 2001;281:F163–F171.......Page 1068
2. Pais VM, Strandhoy JW, Assimos DG. Pathophysiology of urinary tract obstruction. In: Wein AJ, ed. Campbell-Walsh Urology, 9th ed St. Louis: WB Saunders, 2007.......Page 1069
3. Gulmi FA, Felson D, Vaughan ED. Management of post-obstructive diuresis. AUA Update Series. Lesson 23. 1998;27:177–183.......Page 1070
PREGNANCY, UROLITHIASIS......Page 1071
PRIAPISM, GENERAL......Page 1078
PROSTATE CANCER, GENERAL......Page 1085
1. Thompson IM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349:215–224.......Page 1091
2. D’Amico AV, et al. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 2004;351:125–135.......Page 1092
3. Tannock IF, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004;351: 1502–1512.......Page 1093
4. Pilepich MV, et al. Phase III Radiation Therapy Oncology Group (RTOG) trial 86–10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2001;50:1243.......Page 1094
PROSTATE CANCER, HORMONE-REFRACTORY/ANDROGEN INDEPENDENT/CASTRATION RESISTANT......Page 1096
1. Small EJ, Halabi S, Dawson NA, et al. Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: A phase III trial (CALGB 9583). J Clin Oncol 2004;22:1025–1033.......Page 1101
2. Fossa SD, Slee PH, Brausi M, et al. Flutamide vs. prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: A phase III study of the European organization for research and treatment of cancer genitourinary group. J Clin Oncol 2001;19:62–71.......Page 1102
3. Petrylak DP, Tangen CM, Hussain MHA, et al. Docetaxel and estrumustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 2004;351:1513–1520.......Page 1103
4. Tannock IF, de Whit R, Berry WR, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004;351:1502–1512.......Page 1104
5. Saad F, et al. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst 2004;96(11): 879–882.......Page 1105
PROSTATE CANCER, LOCALIZED (T1, T2)......Page 1107
PROSTATE CANCER, LOCALLY ADVANCED (T3–T4)......Page 1115
PROSTATE CANCER, METASTATIC (N+, M+)......Page 1121
PROSTATE CANCER, UROTHELIAL......Page 1128
1. Palou J, Baniel J, Klotz L, et al. Urothelial carcinoma of the prostate. Urology 2007;69(1):50–61.......Page 1133
2. Walsh DL, Chang SS. Dilemmas in the treatment of urothelial cancers of the prostate. Urol Onc 2009;27(4):352–357.......Page 1134
3. Liedberg F, Chebil G, Månsson W. Urothelial carcinoma in the prostatic urethra and prostate: Current controversies. Expert Rev Anticancer Ther 2007;7(3):383–390.......Page 1135
PROSTATE NODULE......Page 1136
PROSTATE, ABSCESS......Page 1143
PROSTATE, BENIGN HYPERPLASIA/HYPERTROPHY (BPH)......Page 1148
PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN)......Page 1155
PROSTATITIS, ACUTE, BACTERIAL (NIH I)......Page 1161
PROSTATITIS, CHRONIC BACTERIAL (NIH II)......Page 1167
PROSTATITIS, CHRONIC NONBACTERIAL, NONINFLAMMATORY (NIH CP/CPPS III B)......Page 1175
PROSTATITIS, CHRONIC NONBACTERIAL INFLAMMATORY (NIH CP/CPPS III A)......Page 1182
PROSTATITIS, GENERAL......Page 1189
1. Krieger JN, Nyberg LJ, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA 1999;282:236–237.......Page 1196
2. Weidner W, Ebner H. Cytological analysis of urine after prostatic massage (VB3): A new technique for discriminating diagnosis of prostatitis. In: Brunner H, Krause W, Rothaug CF, et al., ed. Chronic Prostatitis. Stuttgart: Schattauer, 1985:141–151.......Page 1197
3. Nickel JC, Narayan P, MacKay J, et al. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: A randomized double blind trial. J Urol 2004;171:1594–1597.......Page 1198
4. Alexander RB, Propert KJ, Schaeffer AJ, et al. Chronic Prostatitis Collaborative Research Network: Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: A randomized, double-blind trial. Ann Intern Med 2004;141:581–589.......Page 1199
5. Reissigl AE, Djavan B, Pointner J, et al. Chronic prostatitis/chronic pelvic pain syndrome recurrence after initial effective phytotherapeutic treatment. J Urol 2005;173:S30.......Page 1200
PROSTATITIS, GRANULOMATOUS......Page 1202
PROTEINURIA......Page 1207
1. Adler AI, Stevens RJ, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003;63:225.......Page 1213
2. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005;16:180.......Page 1214
3. Boulware LE, Jaar BG, Tarver-Carr ME, et al. Screening for proteinuria in US adults: A cost-effectiveness analysis. JAMA 2003;290:3101.......Page 1215
4. Strippoli GF, Craig M, Schena FP, et al. Antihypertensive agents for primary prevention of diabetic nephropathy. J Am Soc Nephrol 2005;16:3081.......Page 1216
5. Fuiano G, et al. Current indications for renal biopsy: A questionnaire-based survey. Am J Kidney Dis 2000;35:448.......Page 1217
6. Klahr S, Levey AS, Beck GJ. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994;330:877.......Page 1218
7. Iseki K, Ikemiya Y, Iseki C, et al. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003;64:2326.......Page 1219
PRUNE BELLY (TRIAD) SYNDROME......Page 1220
PSA ELEVATION FOLLOWING LOCAL THERAPY FOR PROSTATE CANCER......Page 1226
PSA ELEVATION, GENERAL......Page 1233
PSEUDOHERMAPHRODITISM, MALE AND FEMALE......Page 1243
PYELONEPHRITIS, ACUTE......Page 1251
PYELONEPHRITIS, CHRONIC......Page 1259
PYELONEPHRITIS, EMPHYSEMATOUS......Page 1266
PYELONEPHRITIS, XANTHOGRANULOMATOUS (XGP)......Page 1272
1. Korkes F, Favoretto RL, Broglio M, et al. Xanthogranulomatous pyelonephritis: Clinical experience with 41 cases. Urology 2008;71: 178–180.......Page 1277
2. Afgan F, Mumtaz S, Ather MH. Preoperative diagnosis of xanthogranulomatous pyelonephritis. Urol J 2007;4:169–173.......Page 1278
3. Loffroy R, Guiu B, Watfa J, et al. Xanthogranulomatous pyelonephritis in adults: Clinical and radiological findings in diffuse and focal forms. Clin Radiol 2007;62:884–890.......Page 1279
4. Vanderbrink BA, et al. Laparoscopic vs. open radical nephrectomy for xanthogranulomatous pyelonephritis Contemporary outcomes analysis. J Endourol 2007;21:65–70.......Page 1280
5. Kapoor R, Vijjan V, Singh K, et al. Is laparoscopic nephrectomy the preferred approach in xanthogranulomatous pyelonephritis? Urology 2006;68:952–955.......Page 1281
PYURIA......Page 1282
RENAL AND PERIRENAL ABSCESS......Page 1288
RENAL AND URETERAL CALCULI (NEPHROLITHIASIS)......Page 1294
RENAL ANGIOMYOLIPOMA......Page 1302
1. Nelson CP, Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma. J Urol 2002;168:1315–1325.......Page 1307
2. Kennelly MJ, Grossman HB, Cho KJ. Outcome analysis of 42 cases of renal angiomyolipoma. J Urol 1994;152:1988–1991.......Page 1308
3. Roy C, Tuchmann C, Lindner V, et al. Renal cell carcinoma with a fatty component mimicking angiomyolipoma on CT. Br J Radiol 1998;71:977–979.......Page 1309
RENAL ARTERY STENOSIS/RENOVASCULAR HYPERTENSION......Page 1310
RENAL CAPSULAR NEOPLASMS......Page 1318
1. Campbell SC, Novick AC, Bukowski RM. Renal tumors. In: Wein AJ, Kavoussi LR, Novick AC, et al, eds. Campbell-Walsh Urology, 9th ed. Philadelphia: Elsevier, 2007.......Page 1322
2. Sharma D, Pradhan S, Aryya NC, et al. Leiomyosarcoma of kidney: A case report with long term result after radiotherapy and chemotherapy. Int Urol Nephrol 2007;39:397–400.......Page 1323
3. Znati K, Chbani L, El Fatemi H, et al. Solitary fibrous tumor of the kidney: A case report and review of the literature. Rev Urol 2007;9:36–40.......Page 1324
4. Kitajima K, Kaji Y, Morita M, et al. Malignant fibrous histiocytoma arising from the renal capsule. Magn Reson Med Sci 2003;2:199–202.......Page 1325
5. Bader DAL, Peres LAB, Bader SLl. Renal Liposarcoma. Intern Braz J Urol 2004;30:214–15.......Page 1326
RENAL CELL CARCINOMA WITH TUMOR THROMBUS......Page 1327
1. Blute ML, Leibovich BC, Lohse CM, et al. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal call carcinoma and venous tumour thrombus. BJU Int 2004;94:33–41.......Page 1333
2. Parekh DJ, Cookson MS, Chapman W, et al. Renal cell carcinoma with renal vein and inferior vena caval involvement: Clinicopathological features, surgical techniques and outcomes. J Urol 2005;173:1897–1902.......Page 1334
3. Lawrentschuk N, Gani J, Riordan R, et al. Multidetector computed tomography vs. magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: A study and review. BJU Int 2005;96:291–295.......Page 1335
4. Shuch B, Riggs SB, LaRochelle JC, et al. Neoadjuvant targeted therapy and advanced kidney cancer: Observations and implications for a new treatment paradigm. BJU Int 2008; electronic publication accessed June 18, 2008.......Page 1336
5. Glazer AA, Novick AC. Long-term follow-up after surgical treatment for renal cell carcinoma extending into the right atrium. J Urol 1996;155:448–450.......Page 1337
RENAL CELL CARCINOMA, GENERAL......Page 1338
1. Jemal A, Siegel R, Ward E, et al. CA Cancer J Clin 2009;59:225–249.......Page 1344
2. Parker AS, et al. Smoking cessation and renal cell carcinoma. Ann Epidemiol 2003;13:245–251.......Page 1345
3. Linehan WM, et al. The genetic basis of cancer of the kidney. J Urol 2003;170:2163–2172.......Page 1346
4. Maturen KE, et al. Renal mass core biopsy: Accuracy and impact on clinical management. AJR 2007;188(2):563–570.......Page 1347
5. Pantuck AJ, et al. Biology of renal cell carcinoma: Changing concepts in classification and staging. Semin Urol Oncol 2001;19:72–79.......Page 1348
6. Eggener S, et al. Surveillance for renal cell carcinoma after surgical management. Am Urol 2001;20:202–207.......Page 1349
RENAL CELL CARCINOMA, LOCALIZED (T1–T2)......Page 1351
RENAL CELL CARCINOMA LOCALLY ADVANCED (T3–T4)......Page 1358
1. Hallscheidt PJ, Bock M, Riedasch G, et al. Diagnostic accuracy of staging renal cell carcinomas using multidetector-row computed tomography and magnetic resonance imaging: A prospective study with histopathologic correlation. J Comput Assist Tomogr 2004;28:333–339.......Page 1364
2. Glazer AA, Novick AC. Preoperative transesophageal echocardiography for assessment of resonance imaging. Urology 1997;49:32–34.......Page 1365
3. Margulis V, Tamboli P, Jacobsohn KM, et al. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma. BJU Int 2007;100(6): 1235–1239.......Page 1366
4. Blute ML, et al. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol 2004;172:465–469.......Page 1367
5. Lam JS, Shvarts O, Leppert JT, et al. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol 2005;174:466–472.......Page 1368
RENAL CELL CARCINOMA, METASTATIC (N+, M+)......Page 1370
Renal Cell Carcinoma, Pediatric......Page 1378
1. Ramphal R, Pappo A, Zielenska M, et al. Pediatric renal cell carcinoma: Clinical, pathologic, and molecular abnormalities associated with the members of the MiT transcription factor family. Am J Clin Pathol 2006;126:349–364.......Page 1382
2. Estrada CR, Suthar AM, Eaton SH, et al. Renal cell carcinoma: Children’s Hospital Boston experience. Urology 2005;66:1296–1300.......Page 1383
3. Indolfi P, Terenziani M, Casale F, et al. Renal cell carcinoma in children: A clinicopathologic study. JCO 2003;21:530–535.......Page 1384
4. Varan A, Akyuz C, Sari N, et al. Renal cell carcinoma in children: Experience of a single center. Nephron Clin Pract 2007;105:c58–c61.......Page 1385
5. Cook A, Lorenzo AJ, Pippi Salle JL, et al. Pediatric renal cell carcinoma: Single institution 25 year case series and initial experience with partial nephrectomy. J Urol 2006;175:1456–1460.......Page 1386
RENAL CYSTS (INTRARENAL, PERIPELVIC, AND PARAPELVIC)......Page 1387
Renal Dysplasia, Hypodysplasia, and Hypoplasia......Page 1394
RENAL ECTOPIA......Page 1402
1. Walsh P. Anomalies of the upper urinary tract. In: Wein AJ, et al., eds. Campbell-Walsh Urology. Philadelphia: Saunders, 2007.......Page 1406
2. Guarino N, Tadini B, Camardi P, et al. The incidence of associated urological abnormalities in children with renal ectopia. J Urol 2004;172:1757.......Page 1407
3. Gupta M, Lee MW. Treatment of stones associated with complex or anomalous renal anatomy. Urol Clin N Am 2007;34(3):431–441.......Page 1408
RENAL FAILURE, ACUTE......Page 1409
1. Nolan CR, Anderson RJ. Hospital-acquired acute renal failure. J Am Soc Nephrol 1998;9:710–718.......Page 1415
2. Merten GJ, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA 2004;291(19):2328–2334.......Page 1416
3. Cardenas A. Hepatorenal syndrome: A dreaded complication of end-stage liver disease. Am J Gastroenterol 2005;100:460–467.......Page 1417
4. Bellomo R, Ronco C. Indications and criteria for initiating renal replacement therapy in the intensive care unit. Kidney Int Suppl 1998;66:S106–S109.......Page 1418
5. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 2005;294(7):813–818.......Page 1419
RENAL FAILURE, CHRONIC......Page 1421
RENAL FUSION ANOMALIES......Page 1429
RENAL INFARCTION......Page 1434
1. Rajeev TP, Kohler TP, Igor Ryndin I, et al. Case report: Renal infarct mimicking renal mass: Further rationale for minimally invasive management. J Endourol 2007;21(9):1065–1068.......Page 1439
2. Lang EK, Sullivan J, Frentz G. Renal trauma: Radiologic studies: Comparison of urographic, computerized tomography, angiography, and radionucleotide studies. Radiology 1985;154:1.......Page 1440
3. Shin-Ichi S, Yoon-Goo K, Joly A, et al. Vascular endothelial growth factor protects rats from renal infarction in thrombotic microangiopathy. Kidney Int 2001;60:1297–1308.......Page 1441
4. Lessman RK, Johnson SF, Coburn JW, et al. Renal artery embolism, clinical features and long term follow-up in 17 cases. Ann Intern Med 1978;89: 477.......Page 1442
RENAL MASS......Page 1443
RENAL ONCOCYTOMA......Page 1451
1. Gudbjartsson T, Hardarson S, Petursdottir V, et al. Renal oncocytoma: A clinicopathological analysis of 45 consecutive cases. BJU Int 2005;96:1275–1279.......Page 1457
2. Romis L, Cindolo L, Patard JJ, et al. Frequency, clinical presentation, and evolution of renal oncocytomas: Multicentric experience from a European database. Eur Urol 2004;45:53–57.......Page 1458
3. Al-Saleem T, Cairns P, Dulaimi EA, et al. The genetics of renal oncocytosis: A possible model for neoplastic progression. Cancer Genet Cytogenet 2004;152:23–28.......Page 1459
4. Dechet CB, Bostwick DG, Blute ML, et al. Renal oncocytoma: Multifocality, bilateralism, metachronous tumor development and coexistent renal cell carcinoma. J Urol 1999;162:40–42.......Page 1460
5. Rohan S, Tu JJ, Kao J, et al. Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes. Clin Cancer Res 2006;12:6937–6945.......Page 1461
RENAL PELVIC TUMORS......Page 1462
RENAL SARCOMA, ADULT AND PEDIATRIC......Page 1470
RENAL TRAUMA, ADULT......Page 1476
1. Buckley JC, McAninch JW. The diagnosis, management, and outcomes of pediatric renal injuries. Urol Clin N Am 2006;33(1):33–40.......Page 1482
2. Heynes CF. Renal trauma: Indications for imaging and surgical exploration. BJU 2004;93:1165–1170.......Page 1483
3. Alsikafinf NF, Rosenstein DI. Staging, evaluation, and nonoperative management of renal injuries. Urol Clin N Am 2006;33(1):13–19.......Page 1484
4. Master VA, McAninch JW. Operative management of renal injuries: Parenchymal and vascular. Urol Clin N Am 2006;33(1):21–31.......Page 1485
RENAL TRAUMA, PEDIATRIC......Page 1486
RENAL TUBULAR ACIDOSIS......Page 1493
1. Laing CM, Unwin RJ. Renal tubular acidosis. J Nephrol 2006;19(Suppl 9):S46–S52.......Page 1499
2. Casaletto JJ. Differential diagnosis of metabolic acidosis. Emerg Med Clin North Am 2005;23:771–787, ix.......Page 1500
3. Rodriguez SJ. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol 2002;13:2160–2170.......Page 1501
4. Domrongkitchaiporn S, Khositseth S, Stitchantrakul W, et al. Dosage of potassium citrate in the correction of urinary abnormalities in pediatric distal renal tubular acidosis patients. Am J Kidney Dis 2002;39:383–391.......Page 1502
RENAL VEIN THROMBOSIS......Page 1503
RETROGRADE EJACULATION......Page 1510
1. Sandler B. Idiopathic retrograde ejaculation. Fertility Sterility 1979;32:474–475.......Page 1515
2. Briganti A, Naspro R, Gallina A. Impact of sexual function of holmium laser enucleation vs. transurethral resection of the prostate: Results of a prospective 2 center randomized trial. J Urol 2006;175(5):1817–1821.......Page 1516
3. Arafa M, El Tabie O. Medical treatment of retrograde ejaculation in diabetic patients: A hope for spontaneous pregnancy. J Sex Med 2008;5:1194–1198.......Page 1517
4. van der Linden PJ, Nan PM, te Velde ER, et al. Retrograde ejaculation: Successful treatment with artificial insemination. Obstet Gynecol 1992;79:126–128.......Page 1518
5. Nikolettos N, Al-Hasani S, Baukloh V, et al. The outcome of intracytoplasmic sperm injection in patients with retrograde ejaculation. Hum Reprod 1999;14:2293–2296.......Page 1519
RETROPERITONEAL ABSCESS......Page 1520
RETROPERITONEAL FIBROSIS (RPF, ORMOND DISEASE)......Page 1526
1. Brown JA, Garlitz CJ, Hubosky SG, et al. Hand-assisted laparoscopic ureterolysis to treat ureteral obstruction secondary to idiopathic retroperitoneal fibrosis: Assessment of a novel technique and initial series. Urology 2006;68(1):46–49.......Page 1532
RETROPERITONEAL MASSES AND CYSTS......Page 1533
RHABDOMYOSARCOMA, PEDIATRIC (SARCOMA BOTRYOIDES)......Page 1539
1. Wu HY, Snyder HM. Pediatric urologic oncology: Bladder, prostate, testis. Urol Clin N Am 2004;31:619–627.......Page 1546
2. Wiener ES, et al. Controversies in the management of paratesticular rhabdomyosarcoma: Is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? Semin Pediatr Surg 2001;10:146–152.......Page 1547
Paidas CN. Results of rhabdomyosarcoma of the bladder and prostate: Is bladder preservation successful? Presented at the Section on Surgery, American Academy of Pediatrics meeting. Chicago, October 28–November 1, 2000.......Page 1548
4. Leuschner I, Harms D, Mattke A, et al. Rhabdomyosarcoma of the urinary bladder and vagina: A clinicopathologic study with emphasis on recurrent disease: A report from the Kiel Pediatric Tumor Registry and the German CWS Study. Am J Surg Pathol 2001;25:856–864.......Page 1549
5. Arndt CAS, Donaldson SS, Anderson JR, et al. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? Cancer 2001;91:2454–2468.......Page 1550
SACRAL AGENESIS, UROLOGIC CONSIDERATIONS......Page 1551
1. Wilmshurst JM, Kelly R, Borzyskowski M. Presentation and outcome of sacral agenesis: 20 years’ experience. Dev Med Child Neurol 1999;41:806–812.......Page 1555
2. Rojansky N, Fasouliotis SJ, Ariel I, et al. Extreme caudal agenesis. J Reprod Med 2002;47:241.......Page 1556
3. Boemers TM, van Gool JD, de Jong TP, et al. Urodynamic evaluation of children with caudal regression syndrome (caudal dysplasia sequence). J Urol 1994;151:1038.......Page 1557
SARCOIDOSIS, UROLOGIC CONSIDERATIONS......Page 1558
SCROTUM AND TESTICLE, MASS......Page 1564
SCROTUM AND TESTICLE, TRAUMA......Page 1572
1. Wessells H, Long L. Penile and genital injuries. Urol Clin North Am 2006;33:117–126.......Page 1578
2. Morey AF, Metro MJ, Carney KJ, et al. Consensus on genitourinary trauma: External genitalia. BJU Int 2004;94:507–515.......Page 1579
3. Buckley JC, McAninch JW. Use of ultrasonography for the diagnosis of testicular injuries in blunt scrotal trauma. J Urol 2006;175:175–178.......Page 1580
4. Chandra RV, Dowling RJ, Ulubasoglu M, et al. Rational approach to diagnosis and management of blunt scrotal trauma. Urol 2007;70:230–234.......Page 1581
5. Buckley JC, McAninch JW. Diagnosis and management of testicular ruptures. Urol Clin North Am 2006;33:111–116.......Page 1582
SCROTUM, SQUAMOUS CELL CARCINOMA......Page 1584
SCROTUM, TUMORS, GENERAL......Page 1590
SEMINAL VESICLE, CYSTS AND MASSES......Page 1597
SEXUAL ABUSE, PEDIATRIC......Page 1604
SEXUAL DYSFUNCTION, FEMALE......Page 1609
SEXUALLY TRANSMITTED DISEASES (STD), GENERAL......Page 1614
SICKLE CELL DISEASE, UROLOGIC CONSIDERATIONS......Page 1622
SPERMATIC CORD MASS AND TUMORS......Page 1630
SPERMATOCELE......Page 1638
SPINAL CORD INJURY (SCI), UROLOGIC CONSIDERATIONS......Page 1644
1. Schurch B, de Seze M, Denys P, et al. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: Results of a single treatment, randomized, placebo controlled 6-month study. J Urol 2005;174:196–200.......Page 1650
2. Chancellor M, Gajewski J, Ackman CFD, et al. Long-term follow-up of the North American Multicenter UroLume Trial for the treatment of external detrusor-sphincter dyssynergia. J Urol 1999;161:1545–1550.......Page 1651
3. Linsenmeyer TA, Culkin D. APS recommendations for urological evaluation of patients with spinal cord injury. J Spinal Cord Med 1999;22:139–142.......Page 1652
STROKE (CVA), UROLOGIC CONSIDERATIONS......Page 1653
SUPRAPUBIC PAIN......Page 1659
SYPHILIS......Page 1668
TESTIS, CANCER, GENERAL......Page 1674
TESTIS, CHORIOCARCINOMA......Page 1682
1. Albers P, Siener R, Krege S, et al. Randomized phase III trial comparing retroperitoneal lymph node dissection with 1 course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German testicular cancer study group. J Clin Oncol 2006;26:2966–2972.......Page 1687
2. Feldman DR, Bosl GJ, Sheinfeld J, et al. Medical treatment of advanced testicular cancer. JAMA 2008;299:672–684.......Page 1688
3. Stephenson AJ, Sheinfeld J. Management of patients with low-stage nonseminomatous germ cell testicular cancer. Cur Treat Options Oncol 2005;5:367–377.......Page 1689
4. Tatokoro M, Kasakami S, Sakura M, et al. Successful management of life-threatening choriocarcinoma syndrome with rupture of pulmonary metastatic foci causing hemorrhagic shock. Int J Urol 2008;15:263–264.......Page 1690
TESTIS, EMBRYONAL CARCINOMA......Page 1691
1. Williams SD, et al. Treatment of disseminated germ cell tumors with cis-platinum, bleomycin, and either vinblastine or etoposide. N Engl J Med 1987;316:1435.......Page 1697
2. Donohue JP, et al. Stage I nonseminomatous germ cell testicular cancer—management options and risk benefit considerations. World J Urol 1994;12:170–177.......Page 1698
TESTIS, ENDODERMAL SINUS TUMOR (YOLK SAC TUMOR)......Page 1700
1. Ross JH, Rybicki L, Kay R. Clinical behavior and a contemporary management algorithm for prepubertal testis tumors: A summary of the prepubertal testis tumor registry. J Urol 2002;168:1675–1679.......Page 1705
2. Pohl HG, Shukla AR, Metcalf PD, et al. Prepubertal testis tumors: Actual prevalence rate of histological types. J Urol 2004;172:2370–2372.......Page 1706
3. Mann JR, Raafat F, Robinson K, et al. The United Kingdom children’s cancer study group’s 2nd germ cell tumor study: Carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol 2000;18:3809–3818.......Page 1707
4. Cushing B, Giller R, Cullen JW, et al. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: A pediatric intergroup study—pediatric oncology group 9049 and children’s cancer group 8882. J Clin Oncol 2004;22:2691–2700.......Page 1708
TESTES, LEYDIG CELL TUMOR......Page 1710
TESTIS, NONSEMINOMATOUS GERM CELL TUMORS (NSGCT), GENERAL......Page 1716
TESTIS, PAIN (ORCHALGIA)......Page 1724
1. McConaghy P, Reid M, Loughlin V, et al. Pain after vasectomy. Anaesthesia 1998;53(1):83–86.......Page 1730
2. Granitsiotis P, Kirk D. Chronic testicular pain: An overview. Eur Urol 2004;45(4):430–436.......Page 1731
3. Sandlow JI, Winfield HN, Goldstein M, et al. Surgery of the scrotum and seminal vesicles. In: Wein AJ, et al., eds. Campbell-Walsh Urology, 9th ed. Philadelphia: Saunders, 2007.......Page 1732
4. Sinclair AM, Miller B, Lee LK, et al. Chronic orchalgia: Consider gabapentin or nortriptyline before considering surgery. Int J Urol 2007;14(7):622–625.......Page 1733
5. Levine LA, Matkov GT, Lubenow TR. Microsurgical denervation of the spermatic cord: A surgical alternative in the treatment of chronic orchalgia. J Urol 1996;155(3):1005–1007.......Page 1734
6. Gray CL, Powell CR, Amling CL. Outcomes for surgical management of orchalgia in patients with identifiable intrascrotal lesions. Eur Urol 2001;39(4):455–459.......Page 1735
7. Nangia AK, Myles JL, Thomas AJ JR. Vasectomy reversal for the post-vasectomy pain syndrome: A clinical and histological evaluation. J Urol 2000;164(6):1939–1942.......Page 1736
8. Cohen SP, Foster A. Pulsed radiofrequency as a treatment for groin pain and orchalgia. Urology 2003;61(3):645.......Page 1737
TESTIS, SEMINOMA......Page 1738
TESTIS, SERTOLI CELL TUMOR......Page 1745
TESTIS, TERATOMA, MATURE AND IMMATURE......Page 1752
TESTIS, TUMOR AND MASS, ADULT, GENERAL......Page 1759
TESTIS, TUMOR AND MASS, PEDIATRIC, GENERAL......Page 1767
TESTOSTERONE DECREASED (HYPOGONADISM)......Page 1775
1. Araujo AB, Esche GR, Kupelian V, et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 2007;92:4241–4247.......Page 1781
2. Finkelstein JS, et al. Effects of decreasing the frequency of gonadotropin releasing hormone stimulation on gonadotropin secretion in gonadotropin-releasing hormone-deficient men and perifused rat pituitary cells. J Clin Invest 1988;81:1725–1733.......Page 1782
3. Ding EL, Song Y, Malik VS, et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: A systematic review and meta-analysis. JAMA 2006;295:1288–1299.......Page 1783
5. Laaksonen DE, Niskanen L, Punnonen K, et al. Testosterone and sex hormone binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004;27:1036–1041.......Page 1784
TORSION, TESTIS AND TESTICULAR APPENDAGES......Page 1785
TRANSPLANT REJECTION, RENAL......Page 1792
1. Sunthanthiran M. Acute rejection of renal allografts: Mechanistic insights and therapeutic options. Kidney Int 1997;51:1289–1304.......Page 1797
2. Sunthanthiran M, Strom T. Mechanisms and management of acute renal allograft rejection. Surg Clin North Am 1998;78(1):77–94.......Page 1798
3. Racusen J, et al., Banff 2003 Meeting Report: New diagnostic insights and standards. Am J Transplant 2004;4:1562.......Page 1799
4. Pallardo Mateu CA, et al. Acute rejection and late renal transplant failure: Risk factors and prognosis. Nephrol Dil Transplant 2004;19:38–42.......Page 1800
TUBERCULOSIS, GENITOURINARY......Page 1801
TUNICA ALBUGINEA/PARATESTICULAR TUMORS AND CYSTS......Page 1809
1. Stewart RJ, Martelli H, Oberlin O, et al. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: Results of the malignant mesenchymal tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology. J Clin Oncol 2003;21:793–798.......Page 1815
2. Merguerian PA, Chang B. Pediatric genitourinary tumors. Cur Opin Oncol 2002;14:273–276.......Page 1816
3. Haga K, Kashiwagi A, Nagamori S, et al. Adult paratesticular rhabdomyosarcoma. Nat Clin Pract Urol 2005;2:398–402.......Page 1817
4. Khoubehi B, Mishra V, Ali M, et al. Adult paratesticular tumours. BJU Int 2002;90:707–715.......Page 1818
TRANSURETHRAL RESECTION (TUR) SYNDROME......Page 1819
1. Mebust WK, Holtgrewe HL, Cockett AT. Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243–247.......Page 1825
2. Hahn RG. Fluid and electrolyte dynamics during development of TURP syndrome. Br J Urol 1990;66:79–84.......Page 1826
3. Hahn RG, Sandfeldt L, Nyman CR. Double-blind randomized study of symptoms associated with absorption of glycine 1.5% or mannitol 3% during transurethral resection of the prostate. J Urol 1998;160:397–401.......Page 1827
4. Weissman JD, Weissman BM. Pontine myelinolysis and delayed encephalopathy following the rapid correction of acute hyponatremia. Arch Neurol 1989;46:926–927.......Page 1828
UMBILICAL ABNORMALITY (DRAINAGE AND MASSES)......Page 1830
1. Snyder CL. Current management of umbilical abnormalities and related anomalies. Semin Pediatr Surg 2007;16(1):41–49.......Page 1835
2. Donlon CR, Furdon SA. Assessment of the umbilical cord outside of the delivery room. Part 2. Adv Neonatal Care 2002;2(4):187–197.......Page 1836
3. Pomeranz A. Anomalies, abnormalities, and care of the umbilicus. Pediatr Clin North Am 2004;51(3):819–827.......Page 1837
UNDESCENDED TESTES (CRYPTORCHIDISM)......Page 1838
1. Elert A, Jahn K, Heidenreich A, et al. The familial undescended testis. Kiln Pediatr 2003;215:40–45.......Page 1844
2. Hrebinko RL, Bellinger MF. The limited role of imaging techniques in managing children with undescended testes. J Urol 1993;150:458–460.......Page 1845
3. Docimo SG. The results of surgical therapy for cryptorchidism: A literature review and analysis. J Urol 1995;154:1148–1152.......Page 1846
4. Lee PA, O’Leary LA, Songer NJ, et al. Paternity after unilateral cryptorchidism: A controlled study. Pediatrics 1996;98:676.......Page 1847
URACHAL CARCINOMA......Page 1848
1. Sheldon CA, Clayman RV, Gonzalez R, et al. Malignant urachal lesions. J Urol 1984;131:1–8.......Page 1854
2. Ashley RA, Inman BA, Sebo TJ, et al. Urachal carcinoma: Clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer 2006;107:712–720.......Page 1855
3. Pinthus JH, Haddad R, Trachtenberg J, et al. Population based survival data on urachal tumors. J Urol 2006;175:2042–2047.......Page 1856
4. Siefker-Radtke AO, Urachal carcinoma: Surgical and chemotherapeutic options. Expert Rev Anticancer Ther 2006;6:1715–1721.......Page 1857
5. Galsky MD, Iasonos A, Mironov S, et al. Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinomas. Urology 2007;69:255–259.......Page 1858
6. Siefker-Radke AO, et al. Multimodality management of urachal carcinoma. The MD Anderson Cancer Center experience. J Urol 2003;169:1295–1298.......Page 1859
7. Herr HW, Bochner BH, Sharp DS, et al. Urachal carcinoma: Contemporary surgical outcomes. J Urol 2007;178:74–78.......Page 1860
URETER AND RENAL PELVIC TUMORS, GENERAL......Page 1861
URETER AND RENAL PELVIS, SQUAMOUS CELL CARCINOMA......Page 1868
URETER AND RENAL PELVIS, UROTHELIAL CARCINOMA (TRANSITIONAL CELL CARCINOMA AND CIS)......Page 1874
URETER, INTRAOPERATIVE INJURY......Page 1881
URETER, OBSTRUCTION......Page 1888
URETER, TRAUMA......Page 1894
*Advance 1 grade for bilateral up to Grade III after Moore et al.......Page 1896
URETEROPELVIC JUNCTION OBSTRUCTION......Page 1905
URETHRA, ABSCESS (PERIURETHRAL ABSCESS)......Page 1913
URETHRA, CARCINOMA, GENERAL......Page 1919
URETHRA, CARUNCLE......Page 1926
1. Urakami S, Igawa M, Shiina H, et al. Urethral caruncle with coexistence of intestinal heterotopia. A case report. Int Urol Nephrol 1997;29(3):341–344.......Page 1929
2. Marshall FC, Uson AC, Melicow MM. Neoplasms and caruncles of the female urethra. Surg Gynecol Obstst 1960;110:723.......Page 1930
3. Park DS, Cho TW. Simple solutions for urethral caruncle. J Urol 2004;172(5 Pt 1):1884–1885.......Page 1931
URETHRA, DIVERTICULA, FEMALE......Page 1932
1. Rovner ES. Urethral diverticula: A review and an update. Neurourol Urodyn 2007;26:972–977.......Page 1938
2. Rovner ES. Bladder and urethral diverticula. In: Wein AJ, et al., eds. Campbell-Walsh Urology, 9th ed. Philadelphia: Saunders, 2007.......Page 1939
3. Burrows LJ, Howden NL, Meyn L, et al. Surgical procedures for urethral diverticula in women in the US, 1979–1997. Int Urogynecol J Pelvic Floor Dysfunct 2005;16:158–161.......Page 1940
4. Foster RT, Amundsen CL, Webster GD. The utility of magnetic resonance imaging for diagnosis and surgical planning before transvaginal periurethral diverticulectomy in women. Int Urogynecol J Pelvic Floor Dysfunct 2007;18:315–319.......Page 1941
5. Patel AK, Chapple CR. Female urethral diverticula. Curr Opin Urol 2006;16:248–254.......Page 1942
6. Hosseinzadeh K, Furlan A, Torabi M. Pre- and postoperative evaluation of urethral diverticulum. AJR Am J Roentgenol 2008;190:165–172.......Page 1943
URETHRA, MASS......Page 1944
URETHRA, SQUAMOUS CELL CARCINOMA......Page 1949
1. Swartz MA, Porter MP, Lin DW, et al. Incidence of primary urethral carcinoma in the US. Urology 2006;68:1164–1168.......Page 1955
2. Fadl-Elmula I, Gorunova L, Mandahl N, et al. Chromosome abnormalities in squamous cell carcinoma of the urethra. Genes, Chromosomes, Cancer 1998;23:72–73.......Page 1956
3. Sharp DS, Angermeier KW. Surgery of penile and urethral carcinoma. In: Kavoussi LR, et al., eds., Campbell-Walsh Urology, 9th ed. Philadelphia: Elsevier, 2007.......Page 1957
4. Dalbagni G, Zhang ZF, Lacombe L, et al. Male urethral carcinoma: Analysis of treatment outcome. Urology 1999;53:1126–1132.......Page 1958
5. Dalbagni G, et al. Female urethral carcinoma: An analysis of treatment outcome and a plea for a standardized management strategy. Br J Urol 1998;82:835–841.......Page 1959
URETHRA, STRICTURE......Page 1960
1. Wein AJ, Kavoussi LR, Novick AC, et al. Campbell-Walsh Urology, 9th ed. Philadelphia: Saunders, 2007.......Page 1965
2. Steenkamp JW, Heyns CF, Kock MLS. Internal urethrotomy vs. dilation as treatment for male urethral strictures: A prospective, randomized comparison. J Urol 1997;157:98–101.......Page 1966
3. Heyns CF, Marais DC. Prospective evaluation of the American Urological Association symptom index and peak urinary flow rate for the follow up of men with known urethral stricture disease. J Urol 2002;168:2051–2054.......Page 1967
URETHRA, TRAUMA (ANTERIOR AND POSTERIOR)......Page 1968
URETHRITIS, GONOCOCCAL AND NONGONOCOCCAL......Page 1974
URGENCY, URINARY (FREQUENCY & URGENCY)......Page 1980
URINARY RETENTION, GENERAL......Page 1988
URINARY TRACT INFECTION (UTI), ADULT FEMALE......Page 1995
URINARY TRACT INFECTION (UTI), ADULT MALE......Page 2003
1. Schaeffer AJ, Schaeffer EM. Infections of the urinary tract. In: Wein AJ, et al. Campbell-Walsh Urology, 9th ed. Philadelphia: Saunders, 2007.......Page 2009
2. Nicolle LE, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005;40:643.......Page 2010
3. Ruben FL, Dearwater SR, Norden CW, et al. Clinical infections in the noninstitutionalized geriatric age group: Methods utilized and incidence of infections. The Pittsburgh Good Health Study. Am J Epidemiol 1995;141(2):145.......Page 2011
4. Warren JW, Abrutyn E, Hebel JR, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999;29(4):745–758.......Page 2012
5. Jepson RG, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2008;1:CD001321.......Page 2013
URINARY TRACT INFECTION (UTI), PEDIATRIC......Page 2014
2. Shaikh N, Morone N, Lopez J, et al. Does this child have a urinary tract infection? JAMA 2007;298(24):2895.......Page 2020
3. Bauer R, Kogan B. New developments in the diagnosis and management of pediatric UTIs. Urol Clin N Am 2008;35:47–58.......Page 2021
4. Sedberry-Ross S, Pohl H. Urinary tract infections in children. Curr Urol Rep 2008;9:165.......Page 2022
UROLITHIASIS, ADULT, GENERAL......Page 2024
UROLITHIASIS, CALCIUM OXALATE/PHOSPHATE......Page 2031
UROLITHIASIS, PEDIATRIC, GENERAL......Page 2039
UROLITHIASIS, STAGHORN......Page 2047
UROLITHIASIS, URIC ACID......Page 2054
UROSEPSIS (SEPTIC SHOCK)......Page 2060
UROSTOMY PROBLEMS......Page 2068
VAGINITIS/VULVOVAGINITIS......Page 2075
1. ACOG Committee on Practice Bulletins–Gynecology. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists, Number 72, May 2006: Vaginitis. Obstet Gynecol 2006;107:1195–1206.......Page 2082
2. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2006. MMWR 2006;55(No. RR-11). Online at http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5511a1.htm.......Page 2083
Centers for Disease Control and Prevention. Available at: www.cdc.gov.......Page 2084
4. Spence D, Melville C. Vaginal discharge. BMJ 2007;335:1147–1151.......Page 2085
http://www.wrongdiagnosis.com/phil/html/bacterial-vaginosis/3719.html......Page 2086
http://www.dpd.cdc.gov/DPDx/HTML/Trichomoniasis.htm......Page 2087
7. Nurbhai M, et al. Oral vs. intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev 2007;17(4):CD002845.......Page 2088
8. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2006;(4):CD001500.......Page 2089
9. Bachmann G, Lobo RA, Gut R, et al. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: A randomized controlled trial. Obstet Gynecol 2008;111:67–76.......Page 2090
Nygren P, Fu R, Freeman M, et al. Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis: An update review for the U.S. Preventive Services Task Force. Ann Intern Med 2008;148:220–233.......Page 2091
Nedrow A, Miller J, Walker M, et al. Complementary and alternative therapies for the management of menopause-related symptoms: A systematic evidence review. Arch Intern Med 2006;166:1453–1465.......Page 2092
VARICOCELE, ADULT......Page 2093
1. Levinger U, Gornish M, Gat Y, et al. Is varicocele prevalence increasing with age? Andrologia 2007;39(3):77–80.......Page 2099
2. Sigman M, Jarow JP. Male Infertility. In: Wein AJ, et al., eds. Campbell-Walsh Urology, 9th ed. Philadelphia: Saunders, 2007.......Page 2100
3. Jarow JP, Ogle SR, Eskew LA, et al. Seminal improvement following repair of US detected subclinical varicoceles. J Urol 1996;155(4):1287–1290.......Page 2101
4. Agarwal A, Deepinder F, Cocuzza M, et al. Efficacy of varicocelectomy in improving semen parameters: New meta-analytical approach. Urology 2007;70(3).......Page 2102
5. Al-Kandari AM, Shabaan H, Ibrahim HM, et al. Comparison of Outcomes of different varicocelectomy techniques: Open inguinal, laparoscopic, and subinguinal microscopic varicocelectomy: A randomized clinical trial. Urology 2007;69(3):413–420.......Page 2103
VARICOCELE, PEDIATRIC......Page 2104
VAS DEFERENS, CONGENITAL ABSENCE......Page 2109
1. Vohra S, Morgentaler A. Congenital anomalies of the vas deferens, epididymis, and seminal vesicles. Urology 1997;49(3):313–321.......Page 2114
2. Tizzano EF, Chitayat D, Buchwald M. Cell-specific localization of CFTR mRNA shows developmentally regulated expression in human fetal tissues. Hum Mol Genet 1993;2(3):219–224.......Page 2115
3. Claustres M, Guittard C, Bozon D, et al. Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France. Hum Mutat 2000;16(2):143–156.......Page 2116
4. Radpour R, Gourabi H, Vosough Dizaj A, et al. Genetic investigations of CFTR mutations in congenital absence of vas deferens, uterus and vagina as a cause of infertility. J Androl 2008;29(5):506–513.......Page 2117
5. Schlegel PN, Shin D, Goldstein M. Urogenital anomalies in men with congenital absence of the vas deferens. J Urol 1996;155(5):1644–1648.......Page 2118
VESICOURETERAL REFLUX, ADULT......Page 2119
VESICOURETERAL REFLUX, PEDIATRIC......Page 2125
VON HIPPEL-LINDAU DISEASE/SYNDROME......Page 2132
WILMS TUMOR (NEPHROBLASTOMA)......Page 2140
SECTION II SHORT TOPIC SECTION A to Z......Page 2148
 11-β-HYDROXYLASE (CYP11B1) DEFICIENCY......Page 2149
 21-HYDROXYLASE (CYP21A2) DEFICIENCY......Page 2150
 5-ALPHA-REDUCTASE DEFICIENCY......Page 2151
 AARSKOG SYNDROME (FACIODIGITOGENITAL SYNDROME)......Page 2152
 ABDOMINOPERINEAL RESECTION (APR), UROLOGIC CONSIDERATIONS......Page 2153
 ABRAMS-GRIFFITHS NOMOGRAM......Page 2154
 ACQUIRED RENAL CYSTIC DISEASE......Page 2155
 ACROSOME REACTION ASSAY......Page 2156
 ACTINOMYCOSIS, RENAL......Page 2157
 ACUTE KIDNEY INJURY (AKI)......Page 2158
 ADENOFIBROMA, METANEPHRIC, PEDIATRIC......Page 2159
 ADRENAL CALCIFICATIONS......Page 2160
 ADRENAL CYSTS AND PSEUDOCYSTS......Page 2161
 ADRENAL CYTOMEGALY......Page 2162
 ADRENAL HEMORRHAGE......Page 2163
 ADRENAL HYPOPLASIA......Page 2164
 ADRENAL INCIDENTALOMAS......Page 2165
 ADRENAL MEDULLARY NEUROBLASTOMA......Page 2166
 ADRENAL METASTASES......Page 2167
 ADRENAL MYELOLIPOMA (ADRENAL MYOLIPOMA)......Page 2168
 ADRENALITIS......Page 2169
 ADRENOGENITAL SYNDROME......Page 2170
 ADRENOLEUKODYSTROPHY......Page 2171
 AGING MALE SURVEY......Page 2172
 AL GHORAB CORPORAL SHUNT......Page 2173
 ALAGILLE SYNDROME......Page 2174
 ALKALINE PHOSPHATASE, UROLOGIC CONSIDERATIONS......Page 2175
 ALKAPTONURIA......Page 2176
 ALOPECIA GENITALIUM......Page 2177
 α-FETOPROTEIN......Page 2178
 ALPORT DISEASE/SYNDROME......Page 2179
 ALSTRöM-EDWARDS SYNDROME......Page 2180
 ALZHEIMER DISEASE, UROLOGIC CONSIDERATIONS......Page 2181
 AMERICAN ASSOCIATION FOR THE SURGERY OF TRAUMA ORGAN SEVERITY SCALE: KIDNEY INJURIES......Page 2182
 AMINOACIDURIA......Page 2184
 AMMONIUM CHLORIDE LOADING TEST......Page 2185
 AMMONIUM URATE UROLITHIASIS......Page 2186
 ANAL SPHINCTER TONE AND SENSATION, UROLOGIC CONSIDERATIONS......Page 2187
 ANDERSON-HYNES PYELOPLASTY......Page 2188
 ANDROGEN/ANABOLIC STEROID ABUSE......Page 2189
 ANDROGEN DEFICIENCY IN THE AGING MALE (ADAM) AND ADAM QUESTIONNAIRE......Page 2190
 ANDROGEN DEPRIVATION SYNDROME (ADS)/METABOLIC SYNDROME......Page 2192
 ANDROGEN INSENSITIVITY SYNDROME (AIS; OR ANDROGEN RESISTANCE SYNDROME), COMPLETE AND PARTIAL......Page 2193
 ANGIOKERATOMA OF FORDYCE (PENILE AND SCROTAL ANGIOKERATOMAS)......Page 2195
 ANGIOLYMPHOID HYPERPLASIA, PENILE......Page 2196
 ANGIOMYXOMA, PERINEAL......Page 2197
 ANGIOSARCOMA, GENITOURINARY......Page 2198
 ANOGENITAL INTRAEPITHELIAL NEOPLASIA......Page 2199
 ANORGASMIA/DYSORGASMIA......Page 2200
 ANTERIOR URETHRAL VALVES......Page 2201
 ANTIANDROGEN WITHDRAWAL SYNDROME......Page 2202
 ANTISPERM ANTIBODIES......Page 2203
 APHTHOUS ULCER, EXTERNAL GENITALIA......Page 2204
 ARTERIOVENOUS FISTULA (AVF), RENAL (OR ARTERIOVENOUS MALFORMATION, AVM)......Page 2205
 ARTIFICIAL INSEMINATION (AI)......Page 2206
 ASK-UPMARK KIDNEY......Page 2207
 ASOPA HYPOSPADIAS REPAIR......Page 2208
 ASPERGILLOSIS, GENITOURINARY......Page 2209
 ASPERMIA......Page 2210
 ASSISTED REPRODUCTIVE TECHNOLOGY......Page 2211
 ASTHENOSPERMIA......Page 2212
 ATHLETIC HEMATURIA......Page 2213
 ATOPIC DERMATITIS (ECZEMA), UROLOGIC CONSIDERATIONS......Page 2214
 ATYPICAL ADENOMATOUS HYPERPLASIA OF THE PROSTATE (ADENOSIS)......Page 2215
 ATYPICAL SMALL ACINAR PROLIFERATION, PROSTATE (ASAP)......Page 2216
 AUA (AMERICAN UROLOGIC ASSOCIATION) SYMPTOM INDEX FOR BPH......Page 2217
 AZOOSPERMIA......Page 2218
 BACK PAIN, UROLOGIC CONSIDERATIONS......Page 2219
 BALANITIS XEROTICA OBLITERANS (BXO)......Page 2220
 BALANITIS, ZOON......Page 2221
 BALKAN NEPHROPATHY......Page 2222
 BANFF CLASSIFICATION, TRANSPLANT REJECTION......Page 2223
 BARCAT-REDMAN HYPOSPADIAS REPAIR......Page 2225
 BARTTER SYNDROME......Page 2226
 BASHFUL BLADDER (PARURESIS, SHY BLADDER SYNDROME)......Page 2227
 BCG REFRACTORY TRANSITIONAL CELL CARCINOMA (TCC)......Page 2228
 BCL-2, UROLOGIC CONSIDERATIONS......Page 2229
 BECKWITH-WIEDEMANN SYNDROME......Page 2230
 BEER NEPHROURETERECTOMY......Page 2231
 BEER POTOMANIA......Page 2232
 BEHçET DISEASE......Page 2233
 BELLINI DUCT CARCINOMA (COLLECTING DUCT CARCINOMA)......Page 2234
 BELT PROCEDURE......Page 2235
 BENCHEKROUN ILEAL VALVE......Page 2236
 BERGER DISEASE (IGA NEPHROPATHY)......Page 2237
 BERGMAN SIGN......Page 2238
 βHCG (HUMAN CHORIONIC GONADOTROPIN)......Page 2239
 BETHANECHOL SUPERSENSITIVITY TEST......Page 2240
 BEZOARS (FUNGUS BALLS)......Page 2241
 BIFID SCROTUM......Page 2242
 BIOFEEDBACK, UROLOGIC CONSIDERATIONS......Page 2243
 BIOTHESIOMETRY, PENILE......Page 2244
 BIRT-HOGG-DUBé SYNDROME......Page 2245
 BITES TO PENIS, ANIMAL AND HUMAN......Page 2246
 BK VIRUS, UROLOGIC CONSIDERATIONS......Page 2247
 BLACK-WATER FEVER......Page 2248
 BLADDER AGENESIS......Page 2249
 BLADDER CHORIOCARCINOMA......Page 2250
 BLADDER DIVERTICULUM......Page 2251
 BLADDER EARS......Page 2252
 BLADDER FILLING DEFECTS......Page 2253
 BLADDER HEMANGIOMA......Page 2254
 BLADDER HERNIA......Page 2255
 BLADDER HYPOPLASIA......Page 2256
 BLADDER, INFLAMMATORY PSEUDOTUMOR......Page 2257
 BLADDER LEIOMYOMA......Page 2258
 BLADDER, LYMPHOMA......Page 2259
 BLADDER MASS, DIFFERENTIAL DIAGNOSIS......Page 2260
 BLADDER, METASTASIS TO......Page 2261
 BLADDER NECK CONTRACTURE......Page 2262
 BLADDER NECK HYPERTROPHY......Page 2263
 BLADDER, NEUROFIBROMA......Page 2264
 BLADDER, PARAGANGLIOMA......Page 2265
 BLADDER, PHEOCHROMOCYTOMA......Page 2266
 BLADDER SARCOMA (LEIOMYOSARCOMA/RHABDOMYOSARCOMA)......Page 2267
 BLADDER SMALL-CELL CARCINOMA (OAT CELL, SIGNET RING)......Page 2268
 BLADDER, TEARDROP......Page 2269
 BLADDER TRABECULATION AND CELLULES......Page 2270
 BLADDER, VILLOUS ADENOMA......Page 2271
 BLADDER WALL CALCIFICATION, DIFFERENTIAL DIAGNOSIS......Page 2272
 BLADDER WALL THICKENING, DIFFERENTIAL DIAGNOSIS......Page 2273
 BLASTOMYCOSIS, GENITOURINARY......Page 2274
 BLEOMYCIN TOXICITY......Page 2275
 BLUE DIAPER SYNDROME......Page 2276
 BLUE DOT SIGN......Page 2277
 BLUE NEVUS (MELANOSIS), UROLOGIC CONSIDERATIONS......Page 2278
 BOARI-OCKERBLAD FLAP......Page 2279
 BODY MASS INDEX (BMI), UROLOGIC CONSIDERATIONS......Page 2280
 BONE METASTASIS, UROLOGIC CONSIDERATIONS......Page 2282
 BONE MINERAL DENSITY, UROLOGIC CONSIDERATIONS......Page 2283
 BONE SCAN, UROLOGIC CONSIDERATIONS......Page 2284
 BONNEY TEST (MARSHALL TEST)......Page 2285
 BORS-COMARR CLASSIFICATION OF VOIDING DYSFUNCTION......Page 2286
 BOSNIAK CLASSIFICATION OF RENAL CYSTS......Page 2287
 BOURNE TEST......Page 2288
 BOWENOID PAPULOSIS......Page 2289
 BOYARSKY GUIDELINES FOR BPH......Page 2290
 BRACHYTHERAPY SEED EMBOLUS......Page 2291
 BRAIN METASTASIS, UROLOGIC CONSIDERATIONS......Page 2292
 BRENNER TUMORS......Page 2293
 BRICKER URETERAL ANASTOMOSIS......Page 2294
 BRIGHAM SLING (URETHROPEXY)......Page 2295
 BRINK SCORE......Page 2296
 BRITISH TESTICULAR TUMOR CLASSIFICATION......Page 2297
 BRUNN BUDS AND NESTS (VON BRUNN NESTS)......Page 2298
 BRUSHITE (CALCIUM MONOHYDROGEN PHOSPHATE)......Page 2299
 BTA TESTING (BTA AND BTA STAT URINE TEST)......Page 2300
 BULKING AGENTS, INJECTABLE......Page 2301
 BULLOUS PEMPHIGOID......Page 2303
 BLOOD UREA NITROGEN (BUN), INCREASED/DECREASED......Page 2304
 BURCH COLPOSUSPENSION......Page 2305
 BUSCHKE-LOWENSTEIN TUMOR......Page 2306
 BYAR FLAPS......Page 2307
 CALCIFICATIONS, ABDOMINAL AND PELVIC......Page 2308
 CALCIFICATIONS, BLADDER......Page 2309
 CALCIFICATIONS, RENAL......Page 2310
 CALCINOSIS, IDIOPATHIC SCROTAL......Page 2311
 CALCIUM LOAD AND FAST STUDIES......Page 2312
 CALCIUM SUPPLEMENTATION AND UROLITHIASIS......Page 2313
 CAMEY I AND II ORTHOTOPIC URINARY DIVERSION......Page 2314
 CANAL OF NUCK HYDROCELE AND CYST (FEMALE HYDROCELE)......Page 2315
 CANDIDIASIS—CUTANEOUS, EXTERNAL GENITALIA......Page 2316
 CAPTOPRIL TEST......Page 2317
 CARCINOID TUMORS, GENITOURINARY......Page 2318
 CARCINOSARCOMA, BLADDER......Page 2319
 CARCINOSARCOMA, PROSTATE......Page 2320
 CARNEY SYNDROME......Page 2321
 CARUNCLE, URETHRAL......Page 2322
 CASALE PROCEDURE......Page 2323
 CAT-EYE SYNDROME......Page 2324
 CAUDA EQUINA SYNDROME......Page 2325
 CAUDAL REGRESSION SYNDROME......Page 2326
 CAVERNOSOGRAPHY......Page 2327
 CAVERNOSOMETRY......Page 2328
 CECIL URETHRAL STRICTURE REPAIR......Page 2329
 CECO URETEROCELE......Page 2330
DESCRIPTION A ureterocele is a congenital saccular dilatation of the terminal portion of the ureter. Cecoureteroceles are elongated beyond the ureterocele orifice by tunneling under the trigone and the urethra and represent a subtype of ureterocele.......Page 2331
 CELLO SCROTUM......Page 2332
 CEREBRAL PALSY, UROLOGIC CONSIDERATIONS......Page 2333
 CERVICAL CANCER, UROLOGIC CONSIDERATIONS......Page 2334
 CHANCROID......Page 2335
 CHARGE ASSOCIATION......Page 2336
 CHEMOTHERAPY TOXICITY, UROLOGIC CONSIDERATIONS......Page 2337
 CHLAMYDIA SEXUALLY TRANSMITTED DISEASE......Page 2338
 CHRISTMAS TREE BLADDER......Page 2339
 CHRONIC KIDNEY DISEASE (CKD)......Page 2340
 CHRONIC PELVIC PAIN SYNDROME (CPPS)......Page 2341
 CHRONIC PROSTATITIS SYMPTOM INDEX (CPSI)......Page 2342
 CHURG-STRAUSS SYNDROME......Page 2343
 CHYLOCELE......Page 2344
 CHYLOUS ASCITES......Page 2345
 CIRCUMCISION, ADULT CONSIDERATIONS......Page 2346
 CIRCUMCISION, PEDIATRIC CONSIDERATIONS......Page 2347
 CISPLATIN TOXICITY......Page 2348
 CLITOROMEGALY......Page 2349
 CLONIDINE SUPPRESSION TEST......Page 2350
 CLOSTRIDIUM DIFFICILE COLITIS, UROLOGIC CONSIDERATIONS......Page 2351
 CLOT RETENTION......Page 2352
 COBB COLLAR......Page 2353
 COBRA HEAD SIGN......Page 2354
 COCCIDIOMYCOSIS, GENITOURINARY......Page 2355
 COHEN (“CROSS-TRIGONAL”) URETERAL REIMPLANTATION......Page 2356
 COLLECTING SYSTEM DUPLICATION, COMPLETE......Page 2357
 COLON AND RECTAL CANCER, UROLOGIC CONSIDERATIONS......Page 2358
 COLUMN OF BERTIN, HYPERTROPHIED......Page 2359
 COMPARTMENT SYNDROME, UROLOGIC CONSIDERATIONS......Page 2360
 CONDYLOMATA LATA......Page 2361
 CONGENITAL ADRENAL HYPERPLASIA......Page 2362
 CONGENITAL NEPHROSIS/NEPHROTIC SYNDROME......Page 2367
 CONSTIPATION, UROLOGIC CONSIDERATIONS......Page 2368
 CONTACT DERMATITIS......Page 2369
 CONTRAST-INDUCED NEPHROPATHY (CIN)......Page 2370
 CORDONNIER AND NESBIT URETERAL ANASTOMOSIS......Page 2371
 CORPORA AMYLACEA (CA)......Page 2372
 CORTICAL NECROSIS, ACUTE (RENAL CORTICAL NECROSIS)......Page 2373
 COSTOVERTEBRAL ANGLE TENDERNESS......Page 2374
 COUGH STRESS TEST......Page 2375
 COWPER DUCT CYST......Page 2376
 COWPER GLAND CARCINOMA......Page 2377
 COWPERITIS (INFLAMMATION OF BULBOURETHRAL GLAND)......Page 2378
 CREATININE, SERUM, INCREASED/DECREASED......Page 2379
 CREDé MANEUVER......Page 2380
 CRIBRIFORM CLEAR CELL HYPERPLASIA OF THE PROSTATE......Page 2381
 CRYPTOCOCCUS, GENITOURINARY......Page 2382
 CT SCAN, UROLOGIC CONSIDERATIONS......Page 2383
 CULP-DEWEERD PYELOPLASTY......Page 2384
 CUNNINGHAM CLAMP......Page 2385
 CYSTADENOCARCINOMA, GENITOURINARY......Page 2386
 CYSTADENOMA, GENITOURINARY......Page 2387
 CYSTIC FIBROSIS, UROLOGIC CONSIDERATIONS......Page 2388
 CYSTINOSIS......Page 2389
 CYSTITIS CYSTICA......Page 2390
 CYSTITIS, EOSINOPHILIC......Page 2391
 CYSTITIS, EMPHYSEMATOUS......Page 2392
 CYSTITIS FOLLICULARIS......Page 2393
 CYSTITIS GLANDULARIS AND CYSTITIS GLANDULARIS OF INTESTINAL TYPE......Page 2394
 CYSTITIS, GRANULOMATOUS......Page 2395
 CYSTITIS, POLYPOID AND PAPILLARY......Page 2396
 CYSTITIS, RADIATION......Page 2397
 CYSTITIS, VIRAL......Page 2398
 CYSTOCELE GRADING......Page 2399
 CYSTOGRAM, INDICATIONS AND TECHNIQUE......Page 2400
 CYSTOMETROGRAM......Page 2401
 CYSTOSARCOMA PHYLLODES, PROSTATE......Page 2402
 CYTOKERATIN STAINING......Page 2403
 CYTOLOGY, PROSTATE......Page 2404
 CYTOLOGY, URINARY......Page 2405
 CYTOMEGALOVIRUS, UROLOGIC CONSIDERATIONS......Page 2406
 CYTOXAN (CYCLOPHOSPHAMIDE) TOXICITY......Page 2407
 DAVIS INTUBATED URETEROTOMY......Page 2408
 DEEP VENOUS THROMBOEMBOLISM (DVT) PROPHYLAXIS: AUA GUIDELINES......Page 2409
 DEHYDROEPIANDROSTERONE (DHEA) AND DHEA SULFATE (DHEA-S) BLOOD TEST......Page 2410
 DELAYED NEPHROGRAM......Page 2411
 DEMENTIA AND VOIDING DYSFUNCTION......Page 2412
 DENT DISEASE......Page 2413
 DENYS-DRASH SYNDROME (DDS), UROLOGIC CONSIDERATIONS......Page 2414
 DERMATITIS HERPETIFORMIS......Page 2415
 DERMATOPHYTE, EXTERNAL GENITALIA......Page 2416
 DERMOID CYST, TESTICULAR......Page 2417
 DESMOPLASTIC SMALL ROUND CELL TUMOR......Page 2418
 DE TONI-FANCONI-DEBRE SYNDROME......Page 2419
 DETRUSOR INSTABILITY (DI)......Page 2420
 DEXAMETHASONE SUPPRESSION TEST......Page 2421
 DIABETES INSIPIDUS, UROLOGIC CONSIDERATIONS......Page 2422
 DIETL CRISIS......Page 2423
 DIMERCAPTOSUCCINIC ACID (DMSA) RENAL SCAN......Page 2424
 DIURETIC RENOGRAM......Page 2425
 DOPPLER, PENILE......Page 2426
 DOWN SYNDROME, UROLOGIC CONSIDERATIONS......Page 2427
 DRIBBLING, POST-VOID......Page 2428
 DROMEDARY HUMP......Page 2429
 DROOPING LILY SIGN......Page 2430
 DRUG ERUPTION, FIXED......Page 2431
 DYSFUNCTIONAL VOIDING......Page 2432
 DYSGERMINOMA......Page 2433
 DYSRAPHISM, SPINAL......Page 2434
 ECCHYMOSIS, FLANK......Page 2435
 ECHINOCOCCUS, RENAL......Page 2436
 EDEMA, LOWER EXTREMITY, UROLOGIC CONSIDERATIONS......Page 2437
 EDWARD SYNDROME......Page 2438
 EJACULATION, PAINFUL......Page 2439
 EJACULATORY ANHEDONIA......Page 2440
 EJACULATORY DUCT OBSTRUCTION (EDO)......Page 2441
 ELECTROEJACULATION......Page 2442
 ELECTROMYOGRAPHY, EXTERNAL SPHINCTER......Page 2443
 ELEJALDE SYNDROME......Page 2444
 ELEPHANTIASIS, SCROTUM......Page 2445
 ELIMINATION SYNDROME: DYSFUNCTIONAL, OF CHILDHOOD......Page 2446
 ENCOPRESIS, UROLOGIC CONSIDERATIONS......Page 2447
 ENCRUSTED CYSTITIS AND PYELITIS......Page 2448
 ENDOCARDITIS (SBE) PROPHYLAXIS, UROLOGIC CONSIDERATIONS......Page 2449
 ENDOCERVICOSIS, BLADDER......Page 2450
 ENDOMETRIOID CARCINOMA, PROSTATE......Page 2451
 ENDOMETRIOSIS, GENITOURINARY......Page 2452
 EPCA-2 (EARLY PROSTATE CANCER ANTIGEN)......Page 2453
 EPIDERMOID CYST, TESTICLE......Page 2454
 EPIDIDYMIS, METASTASIS TO......Page 2455
 EPIDIDYMIS, OBSTRUCTION......Page 2456
 ERECTILE DYSFUNCTION INVENTORY OF TREATMENT SURVEY (EDITS)......Page 2457
 ERYSIPELAS, EXTERNAL GENITALIA......Page 2458
 ERYTHEMA MULTIFORME, EXTERNAL GENITALIA......Page 2459
 ERYTHRASMA......Page 2460
 EXCRETORY UROGRAM: INTRAOPERATIVE (SINGLE-SHOT IVP)......Page 2461
 EXPRESSED PROSTATIC SECRETIONS (EPS)......Page 2462
 EXSTROPHY-EPISPADIAS COMPLEX......Page 2463
 EXTRAGONADAL GERM CELL TUMORS (EGCT)......Page 2464
 EXTRAMAMMARY PAGET DISEASE, UROLOGIC CONSIDERATIONS......Page 2465
 FABRY DISEASE/SYNDROME......Page 2466
 FAMILIAL TESTOTOXICOSIS......Page 2467
 FANCONI SYNDROME......Page 2468
 FATTY CASTS......Page 2469
 FECALURIA......Page 2470
 FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER......Page 2471
 FEMINIZING GENITOPLASTY......Page 2472
 FERTILE EUNUCH DISEASE/SYNDROME......Page 2473
 FIBROEPITHELIAL POLYP......Page 2474
 FIBROUS HAMARTOMA OF INFANCY......Page 2475
 FIBROUS PSEUDOTUMOR OF TESTICULAR TUNIC......Page 2476
 FILARIASIS, UROLOGIC CONSIDERATIONS......Page 2477
 FINE NEEDLE ASPIRATION (FNA) OF PROSTATE......Page 2478
 FISH: URINARY FLUORESCENT IN SITU HYBRIDIZATION (UROVYSION TEST)......Page 2479
 FISTULA, ENTEROVESICAL......Page 2480
 FISTULA, RECTOURETHRAL......Page 2481
 FISTULA, URETEROARTERIAL......Page 2482
 FISTULA, VESICOCUTANEOUS......Page 2483
 FISTULA, VESICOUTERINE......Page 2484
 FISTULA, VESICOVAGINAL AND URETEROVAGINAL......Page 2485
 FITZ-HUGH-CURTIS SYNDROME......Page 2486
 FLANK HERNIA FOLLOWING NEPHRECTOMY......Page 2487
 FLUORESCENT CYSTOSCOPY......Page 2488
 FOLEY Y-V PYELOPLASTY......Page 2489
 FOREIGN BODY, BLADDER AND URETHRA......Page 2490
 FOSSA NAVICULARIS DIVERTICULUM......Page 2491
 FOWLER-STEPHENS ORCHIOPEXY......Page 2492
 FRAGILE X SYNDROME......Page 2493
 FRALEY SYNDROME......Page 2494
 FRENCH CATHETER SCALE......Page 2495
 FREQUENCY, URINARY......Page 2496
 FREQUENCY-DYSURIA SYNDROME......Page 2497
 FUHRMAN NUCLEAR GRADING CLASSIFICATION, RENAL CELL CARCINOMA......Page 2498
 FUNGURIA......Page 2499
 FUNICULITIS......Page 2500
 GAMETE INTRAFALLOPIAN TRANSFER (GIFT)......Page 2501
 GANGLIONEUROBLASTOMA, ADRENAL......Page 2502
 GANGLIONEUROMA, ADRENAL......Page 2503
 GARTNER DUCT CYST......Page 2504
 GENITAL PIERCING, UROLOGIC CONSIDERATIONS......Page 2505
 GERM CELL APLASIA (SERTOLI CELL ONLY SYNDROME)......Page 2506
 GIBBON CLASSIFICATION OF VOIDING DYSFUNCTION......Page 2507
 GIBSON INCISION......Page 2508
 GIL-VERNET ORTHOTOPIC URINARY DIVERSION......Page 2509
 GIL-VERNET URETERAL REIMPLANTATION......Page 2510
 GITTES NEEDLE URETHROPEXY......Page 2511
 GLEASON GRADE, TERTIARY PATTERN......Page 2512
 GLEASON GRADING SYSTEM, PROSTATE CANCER......Page 2513
 GLEASON GRADING SYSTEM, MODIFIED......Page 2515
 GLENN-ANDERSON URETERONEOCYSTOSTOMY......Page 2516
 GLOMERULOCYSTIC KIDNEY DISEASE (CORTICAL MICROCYSTIC DISEASE)......Page 2517
 GLOMERULOSCLEROSIS......Page 2518
 GLUCAGON STIMULATION TEST......Page 2519
 GLYCOSURIA, RENAL......Page 2520
 GOLDSTEIN TEST......Page 2521
 GOLDSTON SYNDROME......Page 2522
 GONADAL DYSGENESIS, MIXED......Page 2523
 GONADAL DYSGENESIS, PURE......Page 2524
 GONADOBLASTOMA......Page 2525
 GOODPASTURE SYNDROME......Page 2526
 GOODWIN URETERAL ANASTOMOSIS......Page 2527
 GORLIN SYNDROME......Page 2528
 GOUT, UROLOGIC CONSIDERATIONS......Page 2529
 GOUVERNEUR SYNDROME......Page 2530
 GRANULOMA INGUINALE (DONOVANOSIS)......Page 2531
 GRANULOSA CELL TUMORS......Page 2532
 GRATIFICATION DISORDER......Page 2533
 GRIESS TEST......Page 2534
 GRISS SEX FUNCTION INDEX......Page 2535
 GROIN HERNIA, PEDIATRIC......Page 2536
 GUILLAIN-BARRé (TRANSVERSE MYELITIS) SYNDROME: UROLOGIC CONSIDERATIONS......Page 2537
 GUN SHOT WOUND, BLADDER......Page 2538
 GUN SHOT WOUND, EXTERNAL GENITALIA......Page 2539
 GUN SHOT WOUND, KIDNEY......Page 2540
 GUN SHOT WOUND, URETER......Page 2541
 HAILEY-HAILEY DISEASE (BENIGN FAMILIAL PEMPHIGOID)......Page 2542
 HALD-BRADLEY CLASSIFICATION OF VOIDING DYSFUNCTION......Page 2543
 HAND FOOT SYNDROME......Page 2544
 HAUTMANN POUCH......Page 2545
 HEIKEL-PARKKULAINEN REFLUX CLASSIFICATION SYSTEM......Page 2546
 HEMATOCELE......Page 2547
 HEMATURIA, ATHLETIC (RUNNERS’ HEMATURIA)......Page 2548
 HEMATURIA-DYSURIA SYNDROME......Page 2549
 HEMATURIA-LOIN PAIN SYNDROME......Page 2550
 HEMIZONA ASSAY......Page 2551
 HEMORRHAGE, POSTOPERATIVE, UROLOGIC CONSIDERATIONS......Page 2552
 HEMOSIDERIN, URINARY......Page 2553
 HENOCH-SCHöNLEIN PURPURA......Page 2554
 HEPATITIS A & B (HAV/HBV), UROLOGIC CONSIDERATIONS......Page 2555
 HEPATORENAL SYNDROME......Page 2556
 HEREDITARY LEIOMYOMA RENAL CELL CARCINOMA (HLRCC) SYNDROME......Page 2557
 HERNIA UTERINE INGUINALE......Page 2558
 HIDRADENITIS SUPPURATIVA (ACNE INVERSA), UROLOGIC CONSIDERATIONS......Page 2559
 HINMAN SYNDROME (HINMAN-ALLEN SYNDROME)......Page 2560
 HISTOPLASMOSIS, GENITOURINARY......Page 2561
 HIV NEPHROPATHY......Page 2562
 HODGKIN DISEASE, UROLOGIC CONSIDERATIONS......Page 2563
 HODGSON TYPE I, II, III HYPOSPADIAS REPAIR......Page 2564
 HORSESHOE KIDNEY......Page 2565
 HORTON-DEVINE “FLIP-FLAP” HYPOSPADIAS REPAIR......Page 2566
 HOUNSFIELD UNITS......Page 2567
 HPC-1 (HEREDITARY PROSTATE CANCER 1 LOCUS)......Page 2568
 HPV (HUMAN PAPILLOMA VIRUS), UROLOGIC CONSIDERATIONS......Page 2569
 HUNNER ULCER......Page 2570
 HUTCH DIVERTICULUM......Page 2571
 HYDATID CYST (HYDATID DISEASE)......Page 2572
 HYDROCALYCOSIS......Page 2573
 HYDROCELE OF THE SPERMATIC CORD......Page 2574
 HYMENAL SKIN TAGS......Page 2575
 HYPERCALCEMIA, UROLOGIC CONSIDERATIONS......Page 2576
 HYPERCALCURIA (ABSORPTIVE, RENAL, AND RESORPTIVE)......Page 2577
 HYPERCARBIA DURING LAPAROSCOPY......Page 2580
 HYPERKALEMIA, UROLOGIC CONSIDERATIONS......Page 2581
 HYPERNATREMIA, UROLOGIC CONSIDERATIONS......Page 2582
 HYPEROXALURIA, UROLOGIC CONSIDERATIONS......Page 2583
 HYPERPARATHYROIDISM, UROLOGIC CONSIDERATIONS......Page 2585
 HYPERSPERMIA AND HYPOSPERMIA......Page 2586
 HYPERTENSION, UROLOGIC CONSIDERATION......Page 2587
 HYPOCITRATURIA......Page 2588
 HYPOKALEMIA, UROLOGIC CONSIDERATIONS......Page 2589
 HYPONATREMIA, UROLOGIC CONSIDERATIONS......Page 2590
 IC (INTERSTITIAL CYSTITIS) SYMPTOM INDEX......Page 2593
 ICE WATER TEST......Page 2594
 IMMUNOHISTOCHEMICAL STAINING, UROLOGIC CONSIDERATIONS......Page 2595
 IMPERFORATE HYMEN......Page 2596
 IN VITRO FERTILIZATION (IVF) AND EMBRYO TRANSFER......Page 2597
 INCONTINENCE (URINARY) WITH ORGASM......Page 2598
 INCONTINENCE IMPACT QUESTIONNAIRE (IQ-7)......Page 2599
 INDEVUS URGENCY SEVERITY SCALE (IUSS)......Page 2600
 INDIANA POUCH......Page 2601
 INFERTILE MALE SYNDROME......Page 2602
 INFLAMMATORY BOWEL DISEASE, UROLOGIC CONSIDERATIONS......Page 2603
 INFUNDIBULAR STENOSIS, DIFFERENTIAL DIAGNOSIS......Page 2604
 INFUNDIBULOPELVIC DYSGENESIS......Page 2605
 INGUINAL HERNIA, ADULT, UROLOGIC CONSIDERATIONS......Page 2606
 INGUINAL HERNIA, PEDIATRIC, UROLOGIC CONSIDERATIONS......Page 2607
 INSECT BITE, PENIS AND SCROTUM......Page 2608
 INTERNATIONAL GERM CELL CANCER COLLABORATIVE GROUP (IGCCCG)......Page 2609
 INTERNATIONAL PROSTATE SYMPTOM SCORE (I-PSS)......Page 2611
 INTERSTITIAL NEPHRITIS......Page 2612
 INTRACYTOPLASMIC SPERM INJECTION (ICSI)......Page 2613
 INTRAOPERATIVE FLOPPY IRIS SYNDROME (IFIS)......Page 2614
 INTRAUTERINE INSEMINATION (IUI)......Page 2615
 INTRINSIC SPHINCTER DEFICIENCY (ISD)......Page 2616
 INVERTED PAPILLOMA, BLADDER......Page 2617
 INVERTED PAPILLOMA, URETER AND RENAL PELVIS......Page 2618
 IRS (INTERGROUP RHABDOMYOSARCOMA STUDY) CLINICAL CLASSIFICATION......Page 2619
 JACK STONES......Page 2620
 JARISCH-HERXHEIMER REACTIONS......Page 2621
 JEUNE SYNDROME (ASPHYXIATING THORACIC DYSPLASIA)......Page 2622
 JOINT REPLACEMENT, UROLOGIC CONSIDERATIONS......Page 2623
 JUVENILE GANGRENOUS VASCULITIS, SCROTAL (PYODERMA GANGRENOSUM)......Page 2625
 JUXTAGLOMERULAR CELL TUMOR, KIDNEY......Page 2626
 KALLMANN SYNDROME......Page 2627
 KAPOSI SARCOMA, UROLOGIC CONSIDERATIONS......Page 2628
 KARTAGENER SYNDROME (IMMOTILE CILIA SYNDROME)......Page 2629
 KEGEL EXERCISES......Page 2630
 KELAMI CLASSIFICATION SYSTEM (MODIFIED)......Page 2631
 KELLY CYSTOCELE REPAIR......Page 2632
 KERR KINKS......Page 2633
 KIBRICK TEST......Page 2634
 KIDNEY, METASTASIS TO......Page 2635
 KIDNEY, SUPERNUMERARY......Page 2636
 KLINEFELTER SYNDROME......Page 2637
 KOCK POUCH AND HEMI-KOCK NEOBLADDER......Page 2638
 LABIAL ADHESIONS AND FUSION......Page 2639
 LACTATE DEHYDROGENASE (LDH), UROLOGIC CONSIDERATIONS......Page 2640
 LAPIDES CLASSIFICATION OF VOIDING DYSFUNCTION......Page 2641
 LAURENCE-MOON-BARDET-BIEDL SYNDROME......Page 2642
 LAZY BLADDER SYNDROME (NURSE’S BLADDER)......Page 2643
 LEADBETTER-CLARKE URETERAL ANASTOMOSIS......Page 2644
 LEADBETTER-POLITANO URETERONEOCYSTOSTOMY......Page 2645
 LEAK POINT PRESSURE (LPP)......Page 2646
 LEBAG NEOBLADDER......Page 2647
 LEDUC URETERAL ANASTOMOSIS......Page 2648
 LEIOMYOMATOSIS, HEREDITARY......Page 2649
 LEOPARD SYNDROME......Page 2650
 LERICHE SYNDROME......Page 2651
 LESCH-NYHAN SYNDROME......Page 2652
 LEUKEMIA, UROLOGIC CONSIDERATIONS......Page 2653
 LEUKOPLAKIA, PENIS......Page 2654
 LEUKORRHEA......Page 2655
 LICH-GREGOIR URETERAL REIMPLANTATION......Page 2656
 LICHEN NITIDUS, PENIS......Page 2657
 LICHEN PLANUS, PENIS......Page 2658
 LICHEN SCLEROSIS ET ATROPHICUS......Page 2659
 LICHEN SIMPLEX CHRONICUS (LICHEN SIMPLEX COMPLEX)......Page 2660
 LIFE EXPECTANCY, UROLOGIC CONSIDERATIONS......Page 2661
 LIPOMA, BLADDER......Page 2664
 LIPOMA, SPERMATIC CORD......Page 2665
 LIPOMATOSIS, PELVIC......Page 2666
 LIPOMENINGOCELE, UROLOGIC CONSIDERATIONS......Page 2667
 LIVER METASTASIS, UROLOGIC CONSIDERATIONS......Page 2668
 LOBAR NEPHRONIA......Page 2669
 LORD PROCEDURE......Page 2670
 LOWE SYNDROME......Page 2671
 LOWER URINARY TRACT SYMPTOMS (LUTS)......Page 2672
 LUB SYNDROME......Page 2673
 LYME DISEASE, UROLOGIC CONSIDERATIONS......Page 2674
 LYMPHADENOPATHY, PELVIC AND RETROPERITONEAL......Page 2675
 LYMPHANGIOGRAM, PEDAL......Page 2676
 LYMPHANGIOMA, BLADDER......Page 2677
 LYMPHANGIOMA, RENAL......Page 2678
 LYMPHANGIOMA, SCROTAL......Page 2679
 LYMPHOMA, UROLOGIC CONSIDERATIONS......Page 2680
 LYMPHORETICULAR MALIGNANT NEOPLASM, PENIS......Page 2681
 LYMPHOVASCULAR INVASION, UROLOGIC CONSIDERATIONS......Page 2682
 LYNCH SYNDROME......Page 2683
 MACE PROCEDURE......Page 2684
 MACRO-ORCHIDISM......Page 2685
 MADSEN-IVERSEN SYMPTOM SCORE......Page 2686
 MAG3 RENAL SCAN......Page 2687
 MAGPI HYPOSPADIAS REPAIR......Page 2688
 MAINZ I, II, III POUCH URINARY DIVERSION......Page 2689
 MALACOPLAKIA, GENITOURINARY......Page 2690
 MALE SEXUAL FUNCTION SCALE......Page 2691
 MALE SEXUAL HEALTH QUESTIONNAIRE (MSHQ) AND THE MSHQ SHORT FORM......Page 2692
 MALROTATED KIDNEY......Page 2693
 MARSHALL-MARCHETTI-KRANTZ (MMK) CYSTOURETHROPEXY......Page 2694
 MARTIUS GRAFT......Page 2695
 MATHIEU HYPOSPADIAS REPAIR......Page 2696
 MATURATION ARREST......Page 2697
 MAYER-ROKITANSKY-KUSTER-HAUSER SYNDROME......Page 2698
 MAYO CLINIC GRADING SYSTEM FOR PROSTATE CANCER......Page 2699
 MCCUNE-ALBRIGHT SYNDROME......Page 2700
 MCGUIRE URINAL......Page 2701
 MEATAL STENOSIS, URETHRAL, FEMALE......Page 2702
 MEATAL STENOSIS, URETHRAL, MALE......Page 2703
 MECKEL-GRUBER SYNDROME (MECKEL SYNDROME)......Page 2704
 MEDIAN BAR......Page 2705
 MEDIAN RAPHE CYST......Page 2706
 MEDULLARY CYSTIC KIDNEY......Page 2707
 MEGA PREPUCE......Page 2708
 MEGACALYCOSIS......Page 2709
 MEGACYSTIS, CONGENITAL......Page 2710
 MEGACYSTIS-MEGAURETER SYNDROME......Page 2711
 MEGALOURETHRA......Page 2712
 MELANOMA, ADRENAL......Page 2713
 MELANOMA, GENITOURINARY......Page 2714
 MELANOMA, URETHRAL......Page 2715
 MENKES SYNDROME (MENKES KINKY HAIR DISEASE)......Page 2716
 MENOPAUSE, UROLOGIC CONSIDERATIONS......Page 2717
 MESOTHELIOMA, BENIGN, TESTICULAR TUNIC......Page 2718
 MESOTHELIOMA, MALIGNANT, TESTICULAR TUNIC......Page 2719
 METABOLIC SYNDROME, UROLOGIC CONSIDERATIONS......Page 2720
 METANEPHRIC ADENOFIBROMA......Page 2721
 METANEPHRIC ADENOMA......Page 2722
 METAPYRONE TEST......Page 2723
 MEYER-WEIGERT LAW......Page 2724
 MICHAELIS-GUTMANN BODIES......Page 2725
 MICROLITHIASIS, TESTIS......Page 2726
 MICROPAPILLARY BLADDER CANCER......Page 2727
 MILK OF CALCIUM, URINARY TRACT......Page 2728
 MILK–ALKALI SYNDROME......Page 2729
 MITROFANOFF PRINCIPLE......Page 2730
 MIXED EPITHELIAL STROMAL TUMOR OF THE KIDNEY (MESTK)......Page 2731
 MOLLUSCUM CONTAGIOSUM......Page 2732
 MONFORT TECHNIQUE......Page 2733
 MONTI PROCEDURE......Page 2734
 MORRIS SYNDROME......Page 2735
 MOSKOWITZ VAGINAL PROLAPSE REPAIR......Page 2736
 MOSTOFI (WHO) GRADING SYSTEM, PROSTATE CANCER......Page 2737
 MUCORMYCOSIS, GENITOURINARY......Page 2738
 MUIR-TORRE SYNDROME......Page 2739
 MULBERRY STONES......Page 2740
 MüLLERIAN DUCT REMNANTS AND SYNDROME......Page 2741
 MULTILOCULAR CYSTIC NEPHROMA (MULTIOCULAR CYST)......Page 2742
 MULTIPLE ENDOCRINE NEOPLASIA (MEN I, MEN II)......Page 2743
 MULTIPLE MYELOMA, UROLOGIC CONSIDERATIONS......Page 2744
 MUMPS ORCHITIS......Page 2745
 MURCS ASSOCIATION (MüLLERIAN DUCT, RENAL, AND CERVICAL VERTEBRAL DEFECTS)......Page 2746
 MUSTARDé HYPOSPADIAS REPAIR......Page 2747
 MYCOPLASMA GENITALIUM INFECTION......Page 2748
 MYCOPLASMA HOMINIS, URINARY TRACT INFECTION......Page 2749
 MYOCUTANEOUS FLAPS......Page 2750
 MYOFASCIAL PELVIC PAIN SYNDROME (MPPS)......Page 2751
 MYOGLOBIN NEPHROTOXICITY......Page 2752
 MYOGLOBINURIA......Page 2753
 NAGAMATSU INCISION......Page 2754
 NATIONAL INSTITUTES OF HEALTH (NIH) CHRONIC PROSTATITIS SYMPTOM INDEX (CPSI)......Page 2755
 NCCN (NATIONAL COMPREHENSIVE CANCER NETWORK) GUIDELINES......Page 2756
 NECROSPERMIA......Page 2757
 NELSON SYNDROME......Page 2758
 NEPHRITIS, RADIATION......Page 2759
 NEPHROGENIC ADENOMA AND METAPLASIA......Page 2760
 NEPHROGENIC SYSTEMIC FIBROSIS/FIBROSING DERMATOPATHY (NSF/NFD)......Page 2761
 NEPHRONOPHTHISIS (JUVENILE, INFANTILE, AND ADOLESCENT)......Page 2762
 NEPHROPATHY, ANALGESIC......Page 2763
 NEPHROPATHY, ISCHEMIC......Page 2764
 NEPHROPATHY, MEMBRANOUS......Page 2765
 NEPHROPATHY, MINIMAL CHANGE......Page 2766
 NEPHROPATHY, OBSTRUCTIVE......Page 2767
 NEPHROPATHY, URATE......Page 2768
 NEPHROPTOSIS......Page 2769
 NESBIT CHORDEE REPAIR......Page 2770
 NEUROENDOCRINE TUMORS, GENITOURINARY......Page 2771
 NEUROFIBROMATOSIS, UROLOGIC CONSIDERATIONS......Page 2772
 NEVES-ZINCKE CLASSIFICATION......Page 2773
 NMP-22 TESTING......Page 2774
 NOCTURNAL ERECTIONS, NORMAL AND ABNORMAL......Page 2775
 NOCTURNAL PENILE TUMESCENCE TESTING......Page 2776
 NOCTURNAL POLYURIA......Page 2777
 NOMOGRAMS, UROLOGIC......Page 2778
 NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY (NAION)......Page 2779
 NON-SACRAL NEUROMODULATION......Page 2780
 NOONAN SYNDROME......Page 2781
 N-TELOPEPTIDE, URINARY (NTX)......Page 2782
 NUTCRACKER SYNDROME......Page 2783
 OBTURATOR NERVE INJURY, INTRAOPERATIVE......Page 2784
 OBTURATOR REFLEX, UROLOGIC CONSIDERATIONS......Page 2785
 OLIGOASTHENOTERAT-OSPERMIA......Page 2786
 OLIGOSPERMIA......Page 2787
 OMPHALOCELE-EXSTROPHY OF THE BLADDER—IMPERFORATE ANUS-SPINA BIFIDA DEFECTS (OEIS) COMPLEX......Page 2788
 OPITZ-FRIAS SYNDROME......Page 2789
 ORAL-FACIAL-DIGITAL (OFD) SYNDROME......Page 2790
 ORCHITIS, GRANULOMATOUS......Page 2791
 ORGASMIC PAIN (PAINFUL EJACULATION)......Page 2792
 OSSIFYING RENAL TUMOR OF INFANCY......Page 2793
 OSTEITIS PUBIS, UROLOGIC CONSIDERATIONS......Page 2794
 OSTEOPOROSIS AND OSTEOPENIA, UROLOGIC CONSIDERATIONS......Page 2795
 OVARIAN CANCER, UROLOGIC CONSIDERATIONS......Page 2797
 OVARIAN REMNANT SYNDROME......Page 2798
 OVARIAN VEIN SYNDROME......Page 2799
 OXYLATE-ASSOCIATED RENAL DISEASE......Page 2800
 P53, UROLOGIC CONSIDERATIONS......Page 2801
 PAD TESTING......Page 2802
 PAGANO URETERAL ANASTOMOSIS......Page 2803
 PAGE KIDNEY......Page 2804
 PAGET DISEASE, ANOGENITAL/EXTRAMAMMARY......Page 2805
 PAGET DISEASE, BONE......Page 2806
 PAINFUL BLADDER SYNDROME (PBS)......Page 2807
 PANETH CELL-LIKE CHANGE, PROSTATE......Page 2808
 PAPILLARY ADENOMA PROSTATIC UTRICLE......Page 2809
 PAPILLARY UROTHELIAL NEOPLASM OF LOW MALIGNANT POTENTIAL (PUNLMP)......Page 2810
 PAPILLOMA, BLADDER......Page 2811
 PAPILLOMA, RENAL PELVIS......Page 2812
 PAPILLORENAL SYNDROME......Page 2813
 PAQUIN URETERAL REIMPLANTATION......Page 2814
 PARASTOMAL HERNIA......Page 2815
 PARTIN TABLES......Page 2816
 PATAU SYNDROME......Page 2817
 PATIENT PERCEPTION OF BLADDER CONDITION (PPBC)......Page 2818
 PATIENT PERCEPTION OF INTENSITY OF URGENCY SCALE......Page 2819
 PCA3 DETECT (PROSTATE CANCER GENE 3 URINE ASSAY)......Page 2820
 PEARLY PAPULES OF PENIS......Page 2821
 PEDICULOSIS PUBIS (CRAB LICE/PUBIC LICE)......Page 2822
 PELVIC FLOOR DYSFUNCTION......Page 2823
 PELVIC FRACTURE, UROLOGIC CONSIDERATIONS......Page 2824
 PELVIC LIPOSARCOMA......Page 2825
 PELVIC ORGAN PROLAPSE QUANTIFICATION SYSTEM (POP-Q)......Page 2826
 PELVIC PAIN, MALE......Page 2827
 PELVIS, BIFID......Page 2828
 PELVIS, EXTRARENAL......Page 2829
 PEMPHIGUS FOLIACEUS AND VULGARIS......Page 2830
 PENILE AND CORPORAL BODY MASS......Page 2831
 PENILE BRACHIAL PRESSURE INDEX (PBI)......Page 2832
 PENILE DOPPLER ULTRASOUND PARAMETERS......Page 2833
 PENILE ENHANCEMENT AND LENGTHENING......Page 2834
 PENILE PAIN SYNDROME......Page 2835
 PENILE PROSTHESIS, MODELS AND DESCRIPTIONS......Page 2836
 PENILE REHABILITATION......Page 2838
 PENILE SHORTENING......Page 2839
 PENIS, AGENESIS (APHALLIA)......Page 2840
 PENIS, ANGIOSARCOMA......Page 2841
 PENIS, ARTIFICIAL NODULES (TANCHO NODULES, BULLETUS, FANG MUK, CHAGAN BALLS)......Page 2842
 PENIS, BASAL CELL CARCINOMA......Page 2843
 PENIS, BOWENOID PAPULOSIS......Page 2844
 PENIS, BURIED (CONCEALED/HIDDEN/TRAPPED)......Page 2845
 PENIS, CUTANEOUS HORN......Page 2846
 PENIS, CYSTS......Page 2847
 PENIS, DUPLICATION (DIPHALLUS)......Page 2848
 PENIS, FIXED DRUG ERUPTIONS......Page 2849
 PENIS, HEMANGIOMA (CAVERNOUS HEMANGIOMA)......Page 2850
 PENIS, HIRSUTE PAPILLOMA (PEARLY PENILE PAPULES, CORONAL PAPILLAE)......Page 2851
 PENIS, HYPOPLASIA......Page 2852
 PENIS, KAPOSI SARCOMA......Page 2853
 PENIS, LEIOMYOMA......Page 2854
 PENIS, LEIOMYOSARCOMA......Page 2855
 PENIS, LENGTH, NORMAL......Page 2856
 PENIS, LEUKOPLAKIA......Page 2857
 PENIS, MALIGNANT FIBROUS HISTIOCYTOMA (MFH)......Page 2858
 PENIS, MELANOMA......Page 2859
 PENIS, METASTASIS TO......Page 2860
 PENIS, NEURILEMOMA (SCHWANNOMA)......Page 2861
 PENIS, NEUROFIBROSARCOMA (MALIGNANT SCHWANNOMA)......Page 2862
 PENIS, SCLEROSING LIPOGRANULOMA (PARAFFINOMA)......Page 2863
 PENIS, SCLEROSING NONVENEREAL LYMPHANGITIS......Page 2864
 PENIS, STRANGULATION......Page 2865
 PENIS, SYRINGOMA......Page 2866
 PENIS, THROMBOSIS OF DORSAL VEIN......Page 2867
 PENIS, TORSION......Page 2868
 PENIS, VERRUCOUS CARCINOMA......Page 2869
 PENIS, WEBBED......Page 2870
 PENN POUCH......Page 2871
 PEREYRA URETHROPEXY......Page 2872
 PERINEAL PAIN, DIFFERENTIAL DIAGNOSIS......Page 2873
 PERINEAL TRAUMA (STRADDLE INJURY)......Page 2874
 PERINEURAL INVASION, UROLOGIC CONSIDERATIONS......Page 2875
 PERIPHERAL NEUROPATHY, UROLOGIC CONSIDERATIONS......Page 2876
 PERIURETHRAL ABSCESS......Page 2877
 PERLMAN SYNDROME......Page 2878
 PET SCAN, UROLOGIC CONSIDERATIONS......Page 2879
 PFANNENSTIEL INCISION......Page 2880
 PHIMOSIS, CLITORAL......Page 2881
 PINWORMS, UROLOGIC CONSIDERATIONS......Page 2882
 PIPE STEM URETHRA......Page 2883
 PLAP (PLACENTAL ALKALINE PHOSPHATASE)......Page 2884
 PLASMACYTOMA, BLADDER......Page 2885
 PLASMACYTOMA, TESTICULAR......Page 2886
 PLOIDY ANALYSIS, BLADDER CANCER......Page 2887
 PLOIDY ANALYSIS, PROSTATE CANCER......Page 2888
 POLYARTERITIS NODOSA (PAN), UROLOGIC CONSIDERATIONS......Page 2889
 POLYEMBRYOMA......Page 2890
 POLYOMA VIRUS (BK, JC), UROLOGIC CONSIDERATIONS......Page 2891
 POLYORCHIDISM......Page 2892
 POLYPOID CYSTITIS......Page 2893
 POLYPOID URETHRITIS......Page 2894
 POLYTHELIA, UROLOGIC CONSIDERATIONS......Page 2895
 POLYURIA......Page 2896
 POST-ATROPHIC HYPERPLASIA OF THE PROSTATE......Page 2897
 POSTCOITAL PROPHYLACTIC ANTIBIOTICS......Page 2898
 POSTCOITAL TEST......Page 2899
 POSTOPERATIVE SPINDLE CELL NODULE, BLADDER......Page 2900
 POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER......Page 2901
 POST-VASECTOMY SYNDROME......Page 2902
 POST-VOID DRIBBLING......Page 2903
 POTASSIUM SENSITIVITY TESTING......Page 2904
 POTTER SYNDROME/POTTER FACIES......Page 2905
 POUCHITIS......Page 2906
 PRADER-WILLI SYNDROME......Page 2907
 PRECOCIOUS PUBERTY......Page 2908
 PREGNANCY, BACTERIURIA, PYURIA, AND URINARY TRACT INFECTION......Page 2909
 PREGNANCY, HEMATURIA......Page 2910
 PREGNANCY, RADIOLOGIC CONSIDERATIONS......Page 2911
 PREGNANCY, RENAL TRANSPLANTATION......Page 2912
 PREGNANCY, URINARY DIVERSION......Page 2913
 PREGNANCY, URINARY TRACT OBSTRUCTION......Page 2914
 PREGNANCY, UROLOGIC MALIGNANCY......Page 2915
 PREGNANCY, UROLOGIC MEDICATIONS......Page 2916
 PREHN SIGN......Page 2917
 PRENTISS MANEUVER......Page 2918
 PREPUTIAL STONES......Page 2919
 PRESSURE-FLOW STUDIES......Page 2920
 PRIAPISM, ISCHEMIC (LOW FLOW, VENO-OCCLUSIVE PRIAPISM)......Page 2921
 PRIAPISM, NONISCHEMIC (HIGH-FLOW, ARTERIAL PRIAPISM)......Page 2922
 PRIAPISM, STUTTERING (INTERMITTENT PRIAPISM)......Page 2923
 PROLACTIN, SERUM LEVEL......Page 2924
 PROPANTHELINE STIMULATION TEST......Page 2925
 PROPHYLACTIC ANTIBIOTICS, AUA GUIDELINES......Page 2926
 PROSTASCINT SCAN......Page 2927
 PROSTATE CANCER, ACTIVE SURVEILLANCE AND WATCHFUL WAITING......Page 2928
 PROSTATE CANCER, BASAL CELL CARCINOMA......Page 2930
 PROSTATE CANCER, CIRCULATING TUMOR CELLS (CTC)......Page 2931
 PROSTATE CANCER, FAMILIAL......Page 2932
 PROSTATE CANCER, LEIOMYOSARCOMA, AND OTHER UNCOMMON SARCOMAS......Page 2933
 PROSTATE CANCER, MUCINOUS ADENOCARCINOMA......Page 2934
 PROSTATE CANCER, PREVENTION (CHEMOPREVENTION)......Page 2935
 PROSTATE CANCER RISK CALCULATORS......Page 2936
 PROSTATE CANCER, RISK STRATIFICATION......Page 2937
 PROSTATE CANCER, SMALL CELL (NEUROENDOCRINE)......Page 2938
 PROSTATE CANCER, SQUAMOUS AND ADENOSQUAMOUS......Page 2940
 PROSTATE, BASAL CELL HYPERPLASIA......Page 2941
 PROSTATE, CALCULI......Page 2942
 PROSTATE, FEMALE......Page 2943
 PROSTATE, HEMATURIA......Page 2944
 PROSTATE HYPERPLASIA, SMALL ACINAR ATYPICAL......Page 2945
 PROSTATE, INFARCTION......Page 2946
 PROSTATE, MASSAGE......Page 2947
 PROSTATE STENTS (UROLUMETM AND SPANNERTM)......Page 2948
 PROSTATIC ACID PHOSPHATASE (PAP)......Page 2949
 PROSTATIC URETHRAL POLYPS......Page 2950
 PROSTATITIS, ASYMPTOMATIC INFLAMMATORY (NIH IV)......Page 2951
 PROSTATITIS, MYCOTIC......Page 2952
 PROSTATITIS, NIH CLASSIFICATION SYSTEM......Page 2953
 PROSTATITIS, STRESS......Page 2954
 PROSTATITIS, TUBERCULOUS......Page 2955
 PROSTATODYNIA......Page 2956
 PROSTHESIS, INFECTED PENILE......Page 2957
 PRURITUS, EXTERNAL GENITALIA, MALE......Page 2958
 PSA, AGE-ADJUSTED......Page 2959
 PSA BOUNCE......Page 2960
 PSA DENSITY (PSAD)......Page 2961
 PSA FAILURE, ASTRO AND PHOENIX DEFINITIONS......Page 2962
 PSA, FREE AND TOTAL......Page 2963
 PSA, RACE-ADJUSTED......Page 2964
 PSA RT-PCR......Page 2965
 PSA VELOCITY (PSAV) AND PSA DOUBLING TIME (PSADT)......Page 2966
 PSEUDODYSSYNERGIA (HINMAN SYNDROME)......Page 2967
 PSEUDOMYXOMA OVARII-LIKE POST-THERAPEUTIC ALTERATION IN PROSTATE ADENOCARCINOMA......Page 2968
 PSMA (PROSTATE-SPECIFIC MEMBRANE ANTIGEN)......Page 2969
 PSOAS ABSCESS, UROLOGIC CONSIDERATIONS......Page 2970
 PSOAS HITCH PROCEDURE......Page 2971
 PSORIASIS, EXTERNAL GENITALIA......Page 2972
 PUDENDAL NERVE ENTRAPMENT/PUDENDAL NEUROPATHY......Page 2973
 PULMONARY METASTASIS, UROLOGIC CONSIDERATIONS......Page 2974
 PYELITIS CYSTICA......Page 2975
 PYELITIS GLANDULARIS......Page 2976
 PYELOGENIC CYST......Page 2977
 PYOCYSTIS......Page 2978
 PYONEPHROSIS......Page 2979
 PYOSPERMIA......Page 2980
 Q-TIP TEST......Page 2981
 QUAKEL CORPORAL SHUNT......Page 2982
 RADIATION, PELVIC, UROLOGIC CONSIDERATIONS......Page 2983
 RADIATION, RENAL AND RETROPERITONEAL, UROLOGIC CONSIDERATIONS......Page 2984
 RADIOPHARMACEUTICALS (PHOSPORUS32, STRONTIUM89, SAMARIUM153 EDTMP)......Page 2985
 RAPID PLASMA REAGIN (RPR) BLOOD TEST......Page 2986
 RAZ BLADDER NECK SUSPENSION (URETHROPEXY)......Page 2987
 RAZ VAGINAL WALL SLING......Page 2988
 RECTAL INJURY DURING RADICAL PROSTATECTOMY......Page 2989
 RECTOCELE, UROLOGIC CONSIDERATIONS......Page 2990
 REFLUX NEPHROPATHY......Page 2991
 REIFENSTEIN SYNDROME......Page 2992
 REINKE CRYSTALS......Page 2993
 REITER SYNDROME (REACTIVE ARTHRITIS)......Page 2994
 RENAL ADENOMA (PAPILLARY ADENOMA)......Page 2995
 RENAL AGENESIS (BILATERAL AND UNILATERAL)......Page 2996
 RENAL ANATOMY, NORMAL RADIOGRAPHIC FINDINGS (SIZES, CALYCES)......Page 2997
 RENAL ARTERY ANEURYSM......Page 2998
 RENAL ARTERY FIBROMUSCULAR DYSPLASIA......Page 2999
 RENAL CARCINOID TUMOR......Page 3000
 RENAL CELL CARCINOMA, CHROMOPHOBE......Page 3001
 RENAL CELL CARCINOMA, PAPILLARY TYPES 1 AND 2......Page 3002
 RENAL CELL CARCINOMA, SARCOMATOID......Page 3003
 RENAL CHOLESTEROL EMBOLISM SYNDROME......Page 3004
 RENAL HEMANGIOMA......Page 3005
 RENAL HEMANGIOPERICYTOMA......Page 3006
 RENAL LEIOMYOMA......Page 3007
 RENAL LEIOMYOSARCOMA......Page 3008
 RENAL LYMPHANGIECTASIA......Page 3009
 RENAL MALROTATION......Page 3010
 RENAL OSTEODYSTROPHY......Page 3011
 RENAL PSEUDOTUMOR......Page 3012
 RENAL SINUS ABNORMALITIES......Page 3013
 RENAL TRANSPLANTATION AND NEOPLASIA......Page 3014
 RENAL VEIN, LEIOMYOSARCOMA......Page 3015
 RENAL–RETINAL SYNDROME......Page 3016
 RENIN, PLASMA AND RENAL VEIN......Page 3017
 RENINOMA (RENIN-SECRETING JUXTAGLOMERULAR CELL TUMOR)......Page 3018
 RENO-ALIMENTARY FISTULA......Page 3019
 RENO-BRONCHIAL FISTULA......Page 3020
 RENOMEDULLARY INTERSTITIAL CELL TUMOR......Page 3021
 RESIDUAL URINE (POST-VOID RESIDUAL [PVR])......Page 3022
 RESISTIVE INDICES (RI)......Page 3023
 RETE TESTIS, ADENOCARCINOMA......Page 3024
 RETROCAVAL/CIRCUMCAVAL URETER......Page 3025
 RETROGRADE URETHROGRAM (RUG), TECHNIQUE......Page 3026
 RETROPERITONEAL HEMATOMA......Page 3027
 RETROPERITONEAL LIPOSARCOMA......Page 3028
 RETROPERITONEAL LYMPHOMA......Page 3029
 RETROPERITONEAL RHEUMATOID NODULES......Page 3030
 RETROPERITONEAL SARCOMA......Page 3031
 RHABDOID TUMOR, MALIGNANT......Page 3032
 RHABDOMYOLYSIS......Page 3033
 RIEGER SYNDROME......Page 3034
 RIFLE CRITERION FOR ACUTE RENAL INJURY......Page 3035
 RIM SIGN (RIM NEPHROGRAM)......Page 3036
 ROBINOW SYNDROME......Page 3037
 ROBSON STAGING SYSTEM......Page 3038
 ROKITANSKY-KUSTER-HOUSER SYNDROME......Page 3039
 ROSEWATER SYNDROME......Page 3040
 ROVSING POLYCYSTIC KIDNEY OPERATION......Page 3041
 ROVSING SYNDROME......Page 3042
 SACRAL NEUROMODULATION......Page 3043
 SCABIES, UROLOGIC CONSIDERATIONS......Page 3044
 SCARDINO-PRINCE PYELOPLASTY......Page 3045
 SCHILLER-DUVAL BODIES......Page 3046
 SCHISTOSOMIASIS, UROLOGIC CONSIDERATIONS......Page 3047
 SCHWANNOMA, RENAL......Page 3048
 SCLERODERMA, UROLOGIC CONSIDERATIONS......Page 3049
 SCLEROSING ADENOSIS OF THE PROSTATE......Page 3050
 SCROTAL PEARLS (SCROTOLITHS)......Page 3051
 SCROTUM, ACCESSORY AND ECTOPIC......Page 3052
 SCROTUM, BIFID......Page 3053
 SCROTUM, ENGULFMENT (PENOSCROTAL TRANSPOSITION)......Page 3054
 SCROTUM, EPIDERMAL INCLUSION CYST......Page 3055
 SCROTUM, FAT NECROSIS......Page 3056
 SCROTUM, GIANT NEUROLEMMOMA......Page 3057
 SCROTUM, HEMANGIOMA......Page 3058
 SCROTUM, HYPOPLASIA......Page 3059
 SCROTUM, IDIOPATHIC CALCINOSIS......Page 3060
 SEAPI INCONTINENCE CLASSIFICATION SYSTEM......Page 3061
 SEBORRHEIC DERMATITIS......Page 3062
 SEMEN ANALYSIS, ABNORMAL FINDINGS AND TERMINOLOGY......Page 3063
 SEMEN ANALYSIS, TECHNIQUE, NORMAL VALUES......Page 3065
 SEMEN LEUKOCYTES......Page 3067
 SEMINAL VESICLE AGENESIS......Page 3068
 SEMINAL VESICLE, AMYLOIDOSIS......Page 3069
 SEMINAL VESICLE, CARCINOMA......Page 3070
 SEMINAL VESICLE, CYSTS......Page 3071
 SEMINAL VESICULITIS......Page 3072
 SEMINOMA, ANAPLASTIC......Page 3073
 SEMINOMA, CLASSIC......Page 3074
 SEMINOMA, SPERMATOCYTIC......Page 3075
 SEX REVERSAL SYNDROME (XX MALE)......Page 3076
 SEXUAL ANHEDONIA/EJACULATORY ANHEDONIA......Page 3077
 SEXUAL FUNCTION SURVEY (SFS) (INTERNATIONAL INDEX OF ERECTILE FUNCTION [IIEF])......Page 3078
 SEXUAL HEALTH INVENTORY FOR MEN (SHIM) SCORE......Page 3079
 SIGNET RING CARCINOMA, PROSTATE......Page 3080
 SILBER VASOEPIDIDYMOSTOMY......Page 3081
 SKENE (PARAURETHRAL) GLAND ADENOCARCINOMA......Page 3082
 SKENE (PARAURETHRAL) GLAND, INFLAMMATION/ADENITIS......Page 3083
 SKIN TAGS, EXTERNAL GENITALIA (ACROCHORDON, PEDUNCULATED PAPILLOMA)......Page 3084
 SLEEP APNEA, UROLOGIC CONSIDERATIONS......Page 3085
 SLING MATERIALS......Page 3086
 SMEGMA......Page 3087
 SMITH-LEMLI-OPITZ SYNDROME......Page 3088
 SOAP-BUBBLE NEPHROGRAM......Page 3089
 SPERM GRANULOMA......Page 3090
 SPERM PENETRATION ASSAY (SPA; HAMSTER TEST)......Page 3091
 SPERM VITALITY......Page 3092
 SPERMATIC CORD, LIPOSARCOMA......Page 3093
 SPINA BIFIDA/SPINA BIFIDA OCCULTA, UROLOGIC CONSIDERATIONS......Page 3094
 SPINAL CORD COMPRESSION, UROLOGIC CONSIDERATIONS......Page 3095
 SPINAL SHOCK......Page 3096
 SPLENIC INJURY DURING RADICAL NEPHRECTOMY......Page 3097
 SPLENOGONADAL FUSION......Page 3098
 SPLENOSIS, UROLOGIC CONSIDERATIONS......Page 3099
 SQUAMOUS METAPLASIA, GENITOURINARY......Page 3100
 STAMEY PROCEDURE (URETHROPEXY)......Page 3101
 STAMEY TEST (3-GLASS TEST, 4-GLASS TEST, MEARES-STAMEY TEST)......Page 3102
 STAUFFER SYNDROME......Page 3103
 STEINSTRASSE......Page 3104
 STING PROCEDURE......Page 3105
 STRANGURIA......Page 3106
 STREAK GONAD......Page 3107
 STRICKLER URETERAL ANASTOMOSIS......Page 3108
 STRUVITE......Page 3109
 STUDER POUCH......Page 3110
 SUPERFICIAL INGUINAL POUCH OF DENIS-BROWNE......Page 3111
 SUPERNUMERARY KIDNEY......Page 3112
 SUPINE STRESS TEST......Page 3113
 SWYER SYNDROME (XY SEX REVERSAL)......Page 3114
 SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE (SIADH)......Page 3115
 SYSTEMIC LUPUS, UROLOGIC CONSIDERATIONS......Page 3116
 TABES DORSALIS......Page 3117
 TAGHAANDAN......Page 3118
 TAKAYASU ARTERITIS, UROLOGIC CONSIDERATIONS......Page 3119
 TANNER STAGES/CLASSIFICATION OF SEXUAL MATURITY......Page 3120
 TERATOMA, SACROCOCCYGEAL, UROLOGIC CONSIDERATIONS......Page 3121
 TESTICULAR FEMINIZATION SYNDROME......Page 3122
 TESTICULAR PROSTHESIS......Page 3123
 TESTIS, CARCINOID......Page 3124
 TESTIS, CARCINOMA IN SITU (CIS)/INTRATUBULAR GERM CELL NEOPLASIA (ITGCN)......Page 3125
 TESTIS, CYSTS......Page 3126
 TESTIS, DERMOID CYST......Page 3127
 TESTIS, LEUKEMIA......Page 3128
 TESTIS, LYMPHOMA......Page 3129
 TESTIS, METASTASIS TO......Page 3130
 TESTIS, MICROLITHIASIS......Page 3131
 TESTIS, NORMAL SIZE......Page 3132
 TESTIS, RETRACTILE......Page 3133
 TESTIS, SEX CORD STROMAL TUMORS......Page 3134
 TESTIS, TERATOMA, EXTRAGONADAL......Page 3135
 TESTOSTERONE (FREE AND TOTAL) LABORATORY TESTING......Page 3136
 TESTOSTERONE REPLACEMENT FOLLOWING RADICAL PROSTATECTOMY......Page 3137
 TETHERED CORD......Page 3138
 TETHERED CORD SYNDROME......Page 3139
 THIERSCH-DUPLAY HYPOSPADIAS REPAIR......Page 3140
 THOMPSON PYELOPLASTY......Page 3141
 THORACIC KIDNEY......Page 3142
 TINEA CRURIS (JOCK ITCH)......Page 3143
 TOILETING PROGRAMS......Page 3144
 TRANSESOPHAGEAL ECHOCARDIOGRAM (TEE), UROLOGIC CONSIDERATIONS......Page 3145
 TRANSSEXUALISM, UROLOGIC CONSIDERATIONS......Page 3146
 TRI-MIX......Page 3147
 TRICHOMONIASIS......Page 3148
 TRIGONITIS......Page 3149
 TRISOMY 4 P......Page 3150
 TRISOMY 8......Page 3151
 TRISOMY 9......Page 3152
 TRISOMY 9 P......Page 3153
 TRISOMY 10 Q......Page 3154
 TRISOMY 11 Q......Page 3155
 TRISOMY 13......Page 3156
 TRISOMY 18 (EDWARDS SYNDROME)......Page 3157
 TRISOMY 20 P......Page 3158
 TRISOMY 21......Page 3159
 TRISOMY 22......Page 3160
 TRISOMY SYNDROME......Page 3161
 TRUE HERMAPHRODITISM......Page 3162
 TUBERCULOSIS, BLADDER AND URETHRA......Page 3163
 TUBERCULOSIS, MALE EXTERNAL GENITALIA......Page 3164
 TUBEROUS SCLEROSIS......Page 3165
 TUMOR LYSIS SYNDROME (TLS)......Page 3166
 TUNICA VAGINALIS TUMORS......Page 3167
 TURNER SYNDROME (XO SYNDROME)......Page 3168
 TURNER-WARWICK INLAY URETHROPLASTY......Page 3169
 UISS-UCLA INTERNATIONAL KIDNEY CANCER STAGING SYSTEM......Page 3170
 UNDERVIRILIZED MALE SYNDROME (MILD ANDROGEN INSENSITIVITY)......Page 3171
 UNINHIBITED DETRUSOR CONTRACTION......Page 3172
 URACHAL ABNORMALITIES......Page 3173
 UREAPLASMA UREALYTICUM......Page 3174
 URETER, AGENESIS/ATRESIA......Page 3175
 URETER, DIVERTICULUM......Page 3176
 URETER, DUPLICATED AND BIFID......Page 3177
 URETER, ECTOPIC (URETERAL ECTOPIA)......Page 3178
 URETER, FIBROEPITHELIAL POLYPS......Page 3179
 URETER, FISH HOOK (REVERSE J)......Page 3180
 URETER, HEMANGIOMA......Page 3181
 URETER, J HOOKING......Page 3182
 URETER, LEIOMYOMA......Page 3183
 URETER, LEIOMYOSARCOMA......Page 3184
 URETER, METASTASIS TO......Page 3185
 URETER, NEPHROGENIC ADENOMA......Page 3186
 URETER, NEUROFIBROMA......Page 3187
 URETER, PIPE-STEM......Page 3188
 URETER, RADIATION INJURY TO......Page 3189
 URETER, RETROCAVAL (CIRCUMCAVAL, POSTCAVAL)......Page 3190
 URETER, SHEPHERD’S CROOK......Page 3191
 URETER, STRICTURE......Page 3192
 URETER, VALVES......Page 3193
 URETERITIS CYSTICA......Page 3194
 URETHRA, ADENOCARCINOMA OF ACCESSORY GLANDS......Page 3195
 URETHRA, ADENOMATOUS POLYPS......Page 3196
 URETHRA, BLEEDING (BLOOD AT MEATUS)......Page 3197
 URETHRA, CALCULI......Page 3198
 URETHRA, CONDYLOMA (WARTS)......Page 3199
 URETHRA, DISCHARGE......Page 3200
 URETHRA, DIVERTICULAR CARCINOMA......Page 3201
 URETHRA, DIVERTICULUM, MALE......Page 3202
 URETHRA, DUPLICATION......Page 3203
 URETHRA, FOREIGN BODY......Page 3204
 URETHRA, HEMANGIOMA......Page 3205
 URETHRA, LEIOMYOMA......Page 3206
 URETHRA, LEIOMYOSARCOMA......Page 3207
 URETHRA, LEUKOPLAKIA......Page 3208
 URETHRA, LYMPHOMA......Page 3209
 URETHRA, MALACOPLAKIA......Page 3210
 URETHRA, MALIGNANT MELANOMA......Page 3211
 URETHRA, MEATUS, NORMAL CALIBER......Page 3212
 URETHRA, METASTASIS TO......Page 3213
 URETHRA, NEPHROGENIC METAPLASIA (ADENOMA)......Page 3214
 URETHRA, OBSTRUCTION......Page 3215
 URETHRA, POLYPS (FIBROEPITHELIAL, ADENOMATOUS, INFLAMMATORY)......Page 3216
 URETHRA, PROLAPSE (FEMALE)......Page 3217
 URETHRA, VILLOUS ADENOMA......Page 3218
 URETHRAL HYPERMOBILITY......Page 3219
 URETHRAL PRESSURE PROFILE (UPP)......Page 3220
 URETHRAL SLING......Page 3221
 URETHRA, STENOSIS/STRICTURE, FEMALE......Page 3222
 URETHRAL SYNDROME......Page 3223
 URETHRITIS, ACUTE......Page 3224
 URETHRITIS, CHRONIC, FEMALE......Page 3225
 URETHRITIS, POLYPOID......Page 3226
 URETHRITIS, SENILE......Page 3227
 URETHROCELE......Page 3228
 URETHRORRHAGIA, IDIOPATHIC......Page 3229
 URGE INCONTINENCE......Page 3230
 URGENCY PERCEPTION SCORE (UPS)......Page 3231
 URINARY ASCITES (UROPERITONEUM)......Page 3232
 URINARY DIVERSION, ELECTROLYTE, AND OTHER ABNORMALITIES......Page 3233
 URINARY DIVERSION, RISK OF MALIGNANCY......Page 3234
 URINARY FLOW RATE (UROFLOWMETRY)......Page 3235
 URINARY RESIDUAL VOLUME (POST-VOID RESIDUAL)......Page 3236
 URINARY RETENTION FOLLOWING BRACHYTHERAPY......Page 3237
 URINARY RETENTION, POSTOPERATIVE......Page 3238
 URINARY TRACT INFECTION (UTI), CATHETER-RELATED......Page 3239
 URINE, ABNORMAL COLOR......Page 3240
 URINE, CYTOLOGY......Page 3241
 URINE, FOAMING......Page 3242
 URINE, ODOR......Page 3243
 URINE, PARTICLES IN......Page 3245
 URINOMA (PERINEPHRIC PSEUDOCYST)......Page 3246
 URINOTHORAX......Page 3247
 URODYNAMICS, INDICATIONS AND NORMAL VALUES......Page 3248
 UROGENITAL DISTRESS INVENTORY (UDI-6)......Page 3249
 UROLITHIASIS, CYSTINE AND CYSTINURIA (HYPERCYSTINURIA)......Page 3251
 UROLITHIASIS, INDINAVIR......Page 3253
 UROLITHIASIS, INFECTIOUS (STRUVITE)......Page 3254
 UROLITHIASIS, MATRIX......Page 3255
 UROLITHIASIS, MELAMINE......Page 3256
 UROLITHIASIS, TRIAMTERENE......Page 3257
 UROLITHIASIS, XANTHINE......Page 3258
 VACTERL ASSOCIATION......Page 3259
 VAGINAL AGENESIS......Page 3260
 VAGINAL ATROPHY, UROLOGIC CONSIDERATIONS......Page 3261
 VAGINAL DISCHARGE, UROLOGIC CONSIDERATIONS......Page 3262
 VAGINAL DUPLICATION......Page 3263
 VAGINAL FUSION......Page 3264
 VAGINAL MASS, NEWBORN......Page 3265
 VAGINAL PESSARIES, UROLOGIC CONSIDERATIONS......Page 3266
 VAGINAL PROLAPSE......Page 3267
 VAGINOSIS......Page 3268
 VALSALVA MANEUVER......Page 3269
 VANISHING TESTIS SYNDROME......Page 3270
 VAS DEFERENS, CALCIFICATION (CVD)......Page 3271
 VAS DEFERENS, OBSTRUCTION......Page 3272
 VASCULITIS, UROLOGIC CONSIDERATIONS......Page 3273
 VASECTOMY, GENERAL CONSIDERATION AND COMPLICATIONS......Page 3274
 VASECTOMY REVERSAL, GENERAL CONSIDERATIONS......Page 3275
 VASOGRAPHY, TECHNIQUE AND INDICATIONS......Page 3276
 VENOUS LEAK SYNDROME......Page 3278
 VESICOBULLOUS LESIONS, EXTERNAL GENITALIA......Page 3279
 VIDEOURODYNAMICS......Page 3281
 VILLOUS ADENOMA, BLADDER/URETHRA......Page 3282
 VIMENTIN, STAINING......Page 3283
 VINCENT CURTSY......Page 3284
 VITILIGO, UROLOGIC CONSIDERATIONS......Page 3285
 VOIDING DIARY (FREQUENCY VOLUME CHART [FVC])......Page 3286
 VOIDING SYMPTOMS, DEFINITIONS (INTERNATIONAL CONTINENCE SOCIETY DEFINITIONS)......Page 3287
 VULVAR MALIGNANCY, UROLOGIC CONSIDERATIONS......Page 3288
 VULVODYNIA......Page 3289
 VURD SYNDROME......Page 3290
 WAGR SYNDROME (WILMS TUMOR, ANIRIDIA, GENITAL ANOMALY, RETARDATION SYNDROME)......Page 3291
 WALLACE URETERAL ANASTOMOSIS......Page 3292
 WALTER REED STAGING SYSTEM, TESTIS CANCER......Page 3293
 WATERHOUSE URETHRAL STRICTURE REPAIR......Page 3294
 WATERHOUSE-FRIDERICHSEN SYNDROME......Page 3295
 WEDDELLITE......Page 3296
 WEGENER GRANULOMATOSIS, UROLOGIC CONSIDERATIONS......Page 3297
 WEISS CRITERION......Page 3298
 WHEWELLITE......Page 3299
 WHITAKER TEST......Page 3300
 WHITLOCKITE......Page 3301
 WHO/ISUP CONSENSUS CLASSIFICATION OF UROTHELIAL NEOPLASMS (1998 AND 2004)......Page 3302
 WILMS TUMOR STAGING SYSTEM, INTERNATIONAL SOCIETY OF PEDIATRIC ONCOLOGY (SIOP)......Page 3303
 WILMS TUMOR STAGING SYSTEM, NATIONAL (NWTS)......Page 3305
 WINTER CORPORAL SHUNT......Page 3307
 WOLFFIAN DUCT REMNANTS......Page 3308
 WOUND DEHISCENCE, UROLOGIC CONSIDERATIONS......Page 3309
 WOUND INFECTION, POSTOPERATIVE, UROLOGIC CONSIDERATIONS......Page 3310
 WUNDERLICH SYNDROME......Page 3311
 XANTHOMA, BLADDER......Page 3312
 X-LINKED SPINAL AND BULBAR ATROPHY SYNDROME (KENNEDY SYNDROME)......Page 3313
 XX GONADAL DYSGENESIS (46,XX)......Page 3314
 XX MALE REVERSAL SYNDROME (XX MALE)......Page 3315
 XXX SYNDROME......Page 3316
 XXXY SYNDROME......Page 3317
 XXY SYNDROME (KLINEFELTER SYNDROME)......Page 3318
 YOLK SAC TUMOR, BLADDER......Page 3319
 YOLK SAC TUMOR, PROSTATE......Page 3320
 YOUNG CLASSIFICATION OF POSTERIOR URETHRAL VALVES......Page 3321
 YOUNG-DEES-LEADBETTER BLADDER RECONSTRUCTION......Page 3322
 YOUNG SYNDROME......Page 3323
 ZELLWEGER SYNDROME (CEREBROHEPATORENAL SYNDROME)......Page 3324
 ZINNER SYNDROME......Page 3325
 ZIPPER ENTRAPMENT......Page 3326
 ZONA PELLUCIDA BINDING ASSAY......Page 3327
SECTION III ALGORITHMS......Page 3328
SECTION IV Urine Studies......Page 3329
URINE ANALYSIS......Page 3330
II. SPOT OR RANDOM URINE STUDIES......Page 3335
CREATININE CLEARANCE AND GLOMERULAR FILTRATION RATE......Page 3337
24-HR URINE STUDIES......Page 3339
SECTION V......Page 3344
SECTION VI......Page 3351
* This chapter is based on data in and modified from Gomella LG, Haist S, Adams A, eds. Clinicians’ Pocket Drug Reference, 2010 Edition. New York: McGraw Hill, 2010.......Page 3508
SECTION VII Appendix......Page 3509
Reproduced with permission from Moore C, Huebler D, Zimmermann T, et al. The Aging Males Symptom Scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol 2004;46:80–87.......Page 3510
Reproduced with permission from the American Urologic Association. Based on data from Wolf JS Jr, et al. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol. 2008;179(4):1379–1390.......Page 3511
Based on American Urological Association. Guideline on the Management of Benign Prostatic Hyperplasia (BPH), Linthicum, MD: American Urological Association Education and Research, Inc; 2003, with permission.......Page 3512
(With permission from Cook Urological, Inc., “French Catheter Scale”)......Page 3513
Based on data from Rosen A, et al. The international index of erectile dysfunction (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822–830, with permission.......Page 3514
Rosen RC, et al. Development and Validation of Four-Item Version of Male Sexual Health Questionnaire to Assess Ejaculatory Dysfunction. Urology 2007;69(5):805–809, with permission.......Page 3515
Litwin M, et al. The National Institutes of Health Chronic Prostatitis Symptom Index: Development and Validation of a New Outcome Measure. J Urol 1999;162(2):369–375, with permission.......Page 3516
Stephenson AJ, Scardino PT, Eastham JA, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2005;23(28):7005–7012, with permission.......Page 3517
**Values are percent probability.......Page 3518
From Rosen RC, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11(6):319–326, with permission.......Page 3519
From Rubin P, Hansen JT, eds. TNM Staging Atlas. Philadelphia: Lippincott Williams & Wilkins; 2007:410.......Page 3520
From Rubin P, Hansen JT, eds. TNM Staging Atlas. Philadelphia: Lippincott Williams & Wilkins; 2007:262.......Page 3521
From Rubin P, Hansen JT, eds. TNM Staging Atlas. Philadelphia: Lippincott Williams & Wilkins; 2007:280.......Page 3522
From Rubin P, Hansen JT, eds. TNM Staging Atlas. Philadelphia: Lippincott Williams & Wilkins; 2007:310.......Page 3523
Note: Ta (noninvasive verrucous carcinoma) and Tis (carcinoma in situ) are Stage Grouping 0.......Page 3524
Note: There is no pathologic stage T1. For pT3a, R1 descriptor indicates positive surgical margin (residual disease). Gleason score (Gl) is only used for stage grouping and not clinical staging.......Page 3525
Note: Ta (noninvasive papillary carcinoma) and Tis (carcinoma in situ) are Stage Grouping 0.......Page 3526
S = serum markers.......Page 3527
Note: Ta (noninvasive papillary, polypoid, or verrucous carcinoma) and Tis (carcinoma in situ) are Stage Grouping 0.......Page 3528
Note: Ta (noninvasive papillary carcinoma) and Tis (carcinoma in situ) are Stage Grouping 0.......Page 3529
Index......Page 3530